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Obesity is one of today's most visible public health problems with worldwide 
incidence at over a billion people. To understand such a vast problem requires one to 
study the issue from different angles. This includes studying how obesity is measured, 
and how metabolic and genetic factors influence the obesity phenotype. This thesis 
investigates the accuracy of the body mass index, a trusted measurement tool, compared 
to an industry standard measuring tool DXA. It also investigates the effects of serum 
calcium on serum lipid levels and how polymorphisms in two genes associated with the 
storage of fat in the human adipocyte affect obesity phenotypes. 
Although body mass index (BMI) is the most widely used measure of obesity, 
debate still exists on how accurately BMI defines obesity. In this study, adiposity status 
defmed by BMI and DXA were compared in a large population to evaluate the accuracy 
of BMI. A total of 1691 adult volunteers from Newfoundland and Labrador (NL) 
participated in the study. BMI and %BF were measured for all subjects following a 12 
hour fasting period. Subjects were categorized as underweight (UW), normal weight 
(NW), overweight (OW), or obese (OB) based on BMI and %BF criteria. Differences 
between the two methods were compared within gender and by age groups. According to 
BMI criteria 1.2% of women were classified as UW, 44.4% as NW, 34.1% as OW and 
20.3% as OB. When women were classified according to %BF criteria 2.2% were UW, 
29.7% were NW, 31.0% were OW and 37.1% were OB. The overall discrepancy between 
the two methods for women was substantial at 34.8% (14.6 %for NW and 16.9% for OB, 
p<0.001). In men the overall discrepancy was 35.2% between BMI and DXA (17.6% for 
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OW an~ l3.5q' fer OB, p~9.99l). Mi~ela~~ification by BMI was dependem on age, 
gender and adiposity status. In conclusion, BMI misclassified adiposity status in 
approximately one third of women and men compared with DXA. Caution should be 
taken when BMI is used in clinical and scientific research as well as clinical practice. 
Some epidemiological evidence shows a link between abnormality of lipid 
profiles and variations in serum calcium. However, it is unknown whether this result was 
influenced by confounding factors. The present study was designed to investigate the 
relationship between serum lipids and calcium. Serum calcium was corrected for 
albumin. Major confounding factors including age, gender, medications, menopause, 
parathyroid hormone (PTH) and 25-0H-vitarnin D status were controlled in analyses. A 
total of 1907 adult subjects from the province of Newfoundland and Labrador (NL), 
Canada participated in the study. Significant positive correlations were detected between 
serum total cholesterol and high density lipoprotein-cholesterol (HDL-c) with variations 
of serum Ca ++ in both genders (p<O.OS-0.0001). Significant positive correlations were 
additionally detected between triglycerides (TAG) and low density lipoprotein-
cholesterol (LDL-c) with Ca++ in women only (p<0.0001) in partial correlation analyses. 
Similar significant results were detected in both females and males not taking any 
medication. Analyses were performed based on menopausal status as well. Significant 
correlations were seen in both pre- and post-menopausal women but higher correlation 
coefficients were observed in pre-menopausal women as compared to post-menopausal 
women. Subjects with low calcium levels had the lowest concentration of total 
cholesterol, TAG, HDL-c and LDL-c, while subjects with high calcium levels had the 
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cholesterol, TAG and LDL-c and serum Ca ++ remained after calcium was adjusted for 25-
0H-vitamin D and PTH. Our results indicate that the abnormality of serum lipid profiles 
are significantly correlated with altered serum Ca ++ levels independent of age, obesity 
status, medication, phosphorus, magnesium, 25-0H-vitamin D and PTH. 
Perilipin (PLIN) is the major component of lipid droplet coating proteins, which 
play a key role in regulating human adipocyte triglyceride metabolism. Adipophilin is 
another lipid droplet coating protein that has been implicated to be involved in 
subcellular lipid trafficking. The association of perilipin and adipophilin with lipid 
storage droplets and lipid trafficking makes them potential candidate genes for obesity 
and lipid abnormality. 
This study investigated whether single nucleotide polymorphisms (SNP) in the 
PLIN and ADFP genes are associated with variations in body composition and serum 
lipid abnormalities. A total of 1269 healthy subjects (1002 females, 267 males) were 
recruited from the genetically homogeneous population of Newfoundland and Labrador 
(NL), Canada. All subjects were at a minimum third generation residents ofNL, between 
the ages of 19-62. Percentages body fat (%FAT) was measured using DXA. Fasting 
serum concentrations of glucose, cholesterol, triacylglyceride (TAG), HDL-C, LDL-C, 
and insulin were measured and the risk ratio for cardiovascular disease ( cholesterol/HDL-
C) was calculated. Genomic DNA was extracted from whole blood. All statistical 
analyses were performed using the statistical software R or SPSS software version 16 for 
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\lliRElews1 with: si~miieanee ~et at p E8.85. Hardy-Weinberg eqtdttbrtmn was tested using 
chi-square analysis. 
Three SNPs located within the PLIN coding regwn were selected. 
SNP:rs4932241, an A/C SNP located in the 3' untranslated region, SNP:rs2289487, an 
AJG SNP located between the 2nd and 3rd exon, and SNP:rs894160, an A/G SNP located 
between the 6th and 7th exon. In ADFP, two A/G polymorphisms were selected. 
SNP:rs3824369 located in the 5' intronic region and SNP:rs35629534 located in the 3' 
untranslated region. Genotyping was performed using TaqMan® validated SNP 
genotyping assays from Applied Biosystems on an ABI 7000 Sequence Detection 
System. All SNPs investigated in this study were in Hardy Weinberg equilibrium. 
The results showed that there were no significant associations within the PLIN 
SNPs for body composition or serum lipid parameters in our population. The results of 
the present study do not support a significant role for genetic variations within the 
perilipin gene in the regulation of body composition and serum lipid profiles in the NL 
population. 
The results revealed a significant association between ADFP SNP:rs3824369 and 
%BF, serum cholesterol and serum LDL-c after controlling for the effects of gender and 
age. Carriers of the major allele of SNP:rs3824369 had significantly higher fasting levels 
of LDL-c and significantly higher fasting levels of serum cholesterol compared to 
homozygote carriers of the minor allele. In addition, carriers of the major allele of SNP: 
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r~3824369 bad sigaifieantly- ftigher 9~:81" eom:t5med to homozygote emriets of dte minot 
allele. To our knowledge this is the first report of an association between a SNP in ADFP 
and variations in body fat or serum lipids. 
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1.1: Obesity in today's society. 
Obesity is one of today' s most visible public health problems with worldwide 
incidence at over a billion people [1]. The prevalence of overweight and obesity is 
increasing at an alarming rate in both the developed and the developing world. This has 
resulted in increased public health challenges worldwide. Thirty three percent (1.3 
billion people) of the worlds adult population was overweight or obese in 2005 with 
estimates of up to 58% of the adult population (3.3 billion) either overweight or obese by 
the year 2030 [2]. Although a larger percentage of individuals are considered overweight 
or obese in developed countries, as developing countries tend to have a much larger 
populations, the absolute number of individuals who are overweight or obese in 
developing countries is much larger [2]. Developing nations are also subject to the same 
influences that contribute to the epidemic of overweight and obesity such as an increase 
in caloric intake, sedentary lifestyles and an aging population. In addition, as developing 
nations tend to have less funding for social programs and health care, this trend is 
expected to continue with drastic health consequences expected in the future [2-4]. 
When compared to the world population, Canadians do not fair much better. In 
2004, 23% of adult Canadians (5.5 million people) over the age of 18 were obese with 
36% (8.6 million people) overweight [5]. This is much higher than the data from the 
1978 Canadian Health Survey which reported a Canadian obesity rate of 13.8% [6]. 
When separated by province, with a few exceptions, obesity rates did not differ much. In 
Canada, Newfoundland and Labrador, has one of the highest rates of obesity [6]. In 2005 
the national body mass index (BMI) average was 22.9 but in Newfoundland it was 33.3. 
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average with a BMI of34.5 [6-7]. 
Health consequences related to obesity range from serious chronic conditions that 
reduce overall quality of life including diabetes, heart disease and hypertension to 
increased risk of premature death. [8]. Data from the 2004 Canadian Community Health 
Survey revealed that fewer than 10% of men and women with a normal ranged BMI 
reported having high blood pressure [7]. This is in contrast to 15% of overweight 
individuals surveyed and 20 % of obese individuals. This pattern was present in both 
men and women. In addition, the proportion of individuals who reported having type 2 
diabetes (DM2) was almost triple that for obese individuals when compared to normal 
BMI individuals [7]. Further, overweight and obesity has been associated with an 
increase in primary care visits [9]. As the obesity problem increases, it is expected that 
the strain on the already over burdened health care system in Canada will increase as 
well. Finally, it has been determined that obesity produces an increased risk of premature 
death as recent research states that current life expectancy in Americans is now estimated 
for the first time to be shorter than parental generations due to the effects of obesity [ 1 0]. 
Even though Canadian obesity rates are lower than those of Americans, this fact could 
soon be true for Canadians. 
1.2: Defining obesity. 
Obesity is defined as an excessively high amount of body fat or adipose tissue in 
relation to lean body mass [ 11]. Currently there are various methods employed to 
measure obesity. The most commonly used measure is BMI. BMI is a measure of the 
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BMI=weight(Kg)lheight\m). It is used as a standard for assessing obesity due to its high 
correlation with weight, and simplicity of computation [3]. The WHO classifies normal 
weight as a BMI of 18.5-24.9 Kg/m2, overweight as 25.0-29.9 Kg/m2, and obese as a 
BMI > 30.0 Kg/m2 [3]. Many countries including Canada have adopted the WHO's BMI 
criteria for defining obesity. 
As easy as BMI is to use, it is not without fault as it fails to account for a number 
of adiposity related-factors including age, gender, and ethnicity. BMI may inaccurately 
classify certain individuals as it is not a direct measure of adiposity or fat distribution. 
For example, body builders and other athletes with a high percentage of muscle mass and 
low body fat can be classified as obese by their BMI even though their body fat 
percentage (%BF) is very low [12]. Thus, a direct measure of %BF can be thought of as 
a more accurate indicator of a person's obesity status [13]. Reference methods such as 
dual energy x-ray absorptiometry (DXA), air-displacement plethysmography, and 
underwater weighing provide a more accurate indication of %BF which is directly linked 
to obesity and its associated disease risk [ 14-17]. 
The use of BMI for the classification of adiposity status and disease risk is based 
on epidemiological associations of BMI with morbidity and mortality [3 , 18]. Despite 
this, numerous studies have produced evidence that BMI has limited ability to accurately 
predict body composition as evidenced by sizeable differences between BMI estimated 
body fat and densitometrically determined body fat [13, 19-21]. Furthermore, the 
relationship between BMI and %BF has been shown to vary with age, sex and ethnicity 
[22-24]. It is therefore essential to identify how well BMI criteria match with more 
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accmate referew:e metbgQ.s ea&i~ ea 9~Bf (~~Bf) tm6 te w bat extent majm factot s such 
as age, gender and adiposity distort the accuracy of BMI. At the present time, there is 
little systematic data available in Canada regarding the accuracy of BMI compared to a 
standard reference method such as DXA, at the population level. 
DXA is a precise, accurate, non-invasive, safe, and convenient technique for 
measuring %BF. DXA employs an X-ray tube to produce two X-ray beams; one high 
energy and one low energy beam. The different attenuation of these beams by the subject 
is measured by specific detectors and used to determine body composition [25]. The 
attenuation of X-rays by a subject depends on the subjects mass and body composition 
[26]. Body composition is then computed by the manufacturers software. Body 
composition data is delivered as bone mineral mass, fat mass and lean body mass and this 
data can be divided into various body compartments for further analysis. 
DXA offers many advantages over other anthropometric measuring tools . . DXA 
is very easy to perform with very little training or expertise needed. In order to operate 
the machine, one must only become familiar with the technique of positioning a subject 
in the proper way for a scan, how to input the relevant data needed about the subject into 
the software interface and how to initiate the scan from the software interface. A short 
lesson on calibration is also needed in order to be able to perform routine calibrations of 
the detecting system. Once the scan is complete, all data generated is automatically 
presented in raw and graphical data form (Figure 1.1). 
DXA is also easy to perform on most subjects. Due to the design of the machine 
and the length of the scan, most subjects are able to tolerate the scan. Subjects are not 
enclosed and only have to lie fairly still on their backs while being scanned. The scan 
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which scan is ordered. DXA is non-invasive so no special preparations are needed before 
the scan in terms of medications, anesthesia or contrast media. In addition, DXA is not 
dependent on other measurements such as height and weight which other measuring tools 
such as BMI and BIA are reliant on. The radiation dose for DXA is very low and ranges 
from 5-7)..1.SV making its use widely applicable[26]. This dose is approximately 1/lOth the 
dose of a standard chest X-Ray and less than a normal day exposure to natural radiation. 
Although DXA offers many benefits, there are deterrents to its use in mainstream 
medicine. The most prominent deterrent is cost. However, with new industry 
competition, more companies are producing DXA machines reducing the costs associated 
with this technology. Although the radiation dose ofDXA is low, there is still a concern 
with radiation exposure, especially in younger populations. In addition, measurement 
accuracy in some patient populations is a problem. DXA calculations assume that the 
hydration of fat-free tissue is constant at 73%. Hydration can range in various patients 
and if a subject contains more than the average amount of water, the software may over 
estimate the actual fat content [25]. As well, all DXA measurements assume that the 
amount of fat that lies over bone is similar and that of the adjacent soft tissue. This is not 
always true, for example, there can be a non-uniformity of adipose tissue distribution in 
the abdomen which can lead to unpredictable errors in measurement of spine bone mass 
density [27]. Lastly, for some patients, especially those with large body widths, DXA 
may over-estimate fat and bone mineral content at depths of greater than 20-25 cm[26]. 
Recent software changes have been developed to overcome some of these problems that 
are caused by tissue thickness [25-26, 28-29]. 
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Figure 1.1: Example of dual-energy X-ray absorptiometry (DXA) scan output from a Lunar 
Prodigy (GE Medical Systems, Madison, WI, USA) DXA scanner. 
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DYe te t:fte ability ef D*A to ~epa:rate and accmately measme body composh1on, 
new classification criteria can be applied to determine obesity status. Bray produced 
obesity classification based on %BF which we used to classify our subjects. Brays 
classification allows for differences found between ethnic groups, genders and between 
age groups. Our subjects consisted of white males and females. Bray classified obesity 
for white females aged 20-39 years as 2::. 39% body fat, for those aged 40-59 years as 2::. 
41%, and for 60-79 year olds, it is 2::. 43%. Obesity for white males aged 20-39 years is 
classified as 2::. 26% body fat, for those aged 40-59 years as 2::. 29%, and for 60-79 year 
olds, it is 2::. 31% body fat (Table 1.1) [30]. 
Table 1.1. Percentage body fat (%BF) cut-off points for women and men 1• 
Women(%BF) Men (%BF) 
Age Underweight Normal Overweight Obese Underweight Normal Overweight Obese 
(yrs) Weight Weight 
20-39 <21 21-32 33-38 39+ <8 8-20 21-25 26+ 
40-59 <23 23-34 35-40 41+ <11 11-22 23-28 29+ 
60-79 <25 25-37 38-42 43+ <13 13-24 25-30 31 + 
1 Adapted from Bray 2003 
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A nwnber of theories have evolved that attempt to explain the cause and or origin 
of the obesity epidemic. The focus of these different theories include explanations of 
evolutionary pressure, fetal programming, ethnic population size increases, a sedentary 
lifestyle or a combination of any or all of these ideas. These theories are reviewed in 
detail elsewhere [31-35]. Regardless of which theory one adopts, obesity is still 
considered a disorder of energy balance which results from either an excess of energy 
intake or a lack of energy expenditure. When energy intake exceeds energy output the 
excess is stored as triglyceride in adipose tissue. The World Health Organization 
attributes the increased prevalence of obesity to the increased conswnption of more 
energy-dense, nutrient-poor foods containing high levels of sugar and saturated fats in 
combination with decreased physical activity [1]. However, not all of us who are 
exposed to excess calories or who have poor exercise habits become obese. Thus, other 
factors must influence body composition in addition to energy balance. 
A link between obesity and genetics has been suspected for over 30 years 
(Feinleib et a/., 1977). Although environmental factors play a large part in the 
development of obesity, the evidence is clear that there is a large underlying genetic 
component and that heritability may play an important part in determining a child's risk 
of developing obesity. It is now well agreed upon that parental obesity is a strong risk 
factor for childhood and adolescent obesity and that the degree of parental obesity also 
influences this risk. This risk is further elevated if both parents are obese [36-37]. 
Although one might be led to believe that this has just as much to do with genetics as 
with environment and child rearing abilities, genetic studies have concluded that the 
predictive value of parental BMI on childhood obesity is mostly due to genetic rather 
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twin studies by Stunkard et al. who estimated a heritability of 0.78 for weight [39] . 
Wardle has recently revealed similar heritability in children determining that genetics 
does play a significant role in development of obesity [ 40]. Wardle determined that even 
though today' s environment has made children fatter than children 20 years ago, the main 
explanation for variations in BMI at the population level is genetic differences between 
individual children. 
In addition to familial inheritance patterns, obesity patterns can also be seen 
between different races (Katzmarzyk et a!., 2000). Studies on body composition patterns 
show that black children have less fat than white children suggesting they have different 
disease risk stratifications [41-43]. In addition, Carroll et al. suggest race determined 
differences in visceral fat measurements. They found that middle aged African American 
men and women had lower visceral adipose tissue despite similar BMI and waist 
circumference measurements compared to the white and Hispanic groups studied. The 
altered relationship between anthropometric measures and visceral adipose tissue 
between races suggests that race and ethnicity should be considered when making 
determinations on obesity disease risk in different populations [44]. Moreover, Rush et 
al. found that the relationship between percentage body fat and BMI varied with 
ethnicity. Their study included 721 subjects from 2 countries and 5 ethnicities. The 
results suggested that a universal BMI may not be appropriate when comparing obesity 
prevalence among different ethnic groups. In other words, BMI does not provide a 
consistent reflection of adiposity and fat distribution across ethnic groups [ 45]. 
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recently, no one gene has been identified as a causative agent for the majority of obesity 
seen in our population. What has been found is that most obesity genes appear to provide 
small contributions or cumulative contributions to human obesity phenotypes. These 
genes are thought to predispose an individual to obesity rather than to be the dominant 
cause. Put simply, the genes load the gun but environmental factors pull the trigger [ 46]. 
However, recent evidence from two independent studies using genome wide association 
scans has revealed that variations in the fat mass and obesity associated gene (FTO) are 
associated with common forms of human obesity [ 4 7 -48]. This is thought to be the first 
evidence of a single gene directly contributing to common forms of obesity [49]. FTO is 
thought to be responsible for 1% of total variance of BMI [50]. Thus a more generally 
accepted theory is that a combination of diet, lifestyle and inheritance contributes to the 
development of complex diseases such as obesity. 
1.4: Association studies and the identification of obesity genes 
There are various ways to study genetic determinants of disease however, 
association studies are a commonly used tool. In their most basic form, association 
studies compare the frequency of alleles or genotypes of a particular variant between 
disease cases and controls (Hirschhorn and Daly, 2005). So far, association studies have 
been successful in identifying many genetic risk factors for common diseases such as 
apolipoprotein E (APOE) for the age of onset and risk of Alzheimer' s disease 
(Strittmatter and Roses, 1996), peroxisome proliferator-activated receptor-gamma 2 
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obesity ( Frayling 2007, Scuteri 2007). 
Risch and Merikangas argued that the association study offers a more powerful 
means of identifying genetic variants that influence a person's susceptibility to complex 
diseases over traditional methods such as linkage analysis (Risch and Merikangas, 1996). 
Adding to this argument, Burton et a/. state that it is more likely the genetic component 
of obesity has a cumulative effect and this effect likely increases susceptibility to obesity 
rather than be the direct cause [51]. It is the increase in susceptibility that variations in 
candidate genes may cause that is the focus of obesity association studies. To address 
these small cumulative effects in candidate genes, association studies have begun to 
incorporate larger and larger sample sizes such as the recent work by Frayling et a/. and 
the discovery of the FTO gene association with obesity. This study included over 38000 
individuals [ 4 7] . 
Although seemingly successful, the association study has been questioned due 
to non-replication of results as well as limitations in the ability to include all possible 
causative genes and polymorphisms[52]. Explanations for lack ofreproducibility usually 
include small sample size, random error, poorly matched control groups, over-
interpretation of data, and positive publication bias [53-54]. However, a good study 
design can overcome all of these problems [55]. In addition, problems with population 
substructure have raised concerns for case control associations [53]. Allelic frequency 
variation between cases and controls may reflect differences in their ancestry rather than 
a relationship to a phenotype of interest [51, 53]. This problem can be reduced by 
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sample [53-54). 
Association studies are classified as either genome-wide or candidate-gene 
association studies [56). Genome-wide association studies are a hypothesis free approach 
requiring the screening of the whole genome with the aim of identifying new, 
unanticipated genetic variants associated with a given disease or trait (49]. This approach 
is a powerful method for identifying genes involved in common diseases, such as obesity, 
since no assumptions are made about their genomic location or their function. As it does 
not rely on familial relatedness, genome wide association studies can use large cohorts of 
cases and controls than typical family based studies. The two major obstacles facing the 
genome-wide approach are the enormous associated cost and the issue of type one errors 
(false positives) when performing multiple tests. However, recent advances in 
technology and increased market competition have significantly reduced the cost of doing 
genome wide association studies. 
New Candidate-gene studies rely on hypotheses generation and identification of 
candidate genes that have a role in the etiology of the disease in question [52]. This 
approach entails genotyping genetic variants, such as single nucleotide polymorphisms 
(SNPs), in or near causative genes in a population and determining whether there is a 
statistical relationship between those variants and the disease phenotype. 
1.5: Adipose Tissue- Adipocyte metabolism and the PAT protein family 
Many genes have been identified by the Human Obesity Gene Map as possible 
candidate genes in the pathogenesis of obesity [57]. When choosing a candidate gene, it 
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obesity is the way fat is stored and released in the body. Adipose tissue is the largest 
energy reservoir in the body [58]. It is found in mammals in two forms: white adipose 
tissue (WAT) and brown adipose tissue (BAT). WAT makes up the majority of adipose 
tissue in the body [59]. However, it has recently been reported that the adult human body 
contains much more BAT than once thought and the role of BAT in obesity is being 
reanalyzed [60]. The focus of this study is WAT and the way its cells (adipocytes) are 
metabolized. 
Adipocytes function primarily to synthesize and store lipids when nutrients are 
abundant, and release fatty acids when nutrients are needed [61]. When caloric intake 
consistently exceeds expenditure, excessive adipose tissue will accwnulate. Under 
conditions of energy abundance, the structure of the adipocyte changes and it will swell 
(to up to six times the original size) and multiply in nwnbers from 40 billion (average 
adult) to as many as 100 billion [62]. It is also known that excessive adipose tissue 
increases one's risk for nwnerous medical conditions such as coronary artery disease, 
hypertension, dyslipidemias, DM2, and cancer [63]. 
Adipose tissue is not just an energy storage site but it is also considered a 
heterogeneous organ. It has been reported that in addition to adipocytes, human adipose 
tissue contains a population of non-characterized cells that are able to undergo 
adipogenic, osteogenic, chondrogenic or miogenic differentiation in vitro [64]. These 
cells are collectively called the stromal-vascular fraction, which also include pre-
adipocytes, endothelial cells, and macrophages [65]. WAT is now recognized as a highly 
dynamic organ, with involvement in metabolic regulation and physiological homeostasis 
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[94]. It was the elisea•reey af th& e,.tek1ne like hormone leptin which is secteted fwm 
adipocytes, that helped shape the theories of adipose tissue as an endocrine organ [66-67] 
. Since then, numerous other adipocytokines have been discovered. The classification of 
these adipocytokines by functional role include appetite and energy balance, immunity, 
insulin sensitivity, angiogenesis, inflammation and acute-phase response, blood pressure, 
lipid metabolism, and hemostasis [ 66, 68]. The main focus of our research was to 
investigate how adipocytes store and release excess food energy and if the genes involved 
influenced these actions. 
To determined how adipocytes store and release energy, the internal structures of 
the fat cell need to be looked at more closely. Adipocytes contain specialized organelles 
known as lipid storage droplets, which regulate the storage and release of intracellular fat 
stores. Lipid storage droplets (LSD) are intracellular organelles found in most cell types. 
These organelles serve mainly as triacylglyceride (TAG) reserves for times of increased 
energy need and LSDs in adipocytes contain the largest reserves of TAG in the body 
[69]. Not only is storing fat in cells advantageous in times of energy need, but the stored 
lipid can also be used as substrate for synthesis of other important cellular molecules, 
such as membrane phospholipids. In addition, the products of TAG hydrolysis, 
(diacylglycerol (DAG) and free fatty acids), may influence cell signaling either directly 
or via subsequent metabolism, (ex fatty acyl coenzyme A). Free fatty acids can also 
influence gene expression by acting as ligands for nuclear receptors, such as the 
peroxisome-proliferator activated receptor (PP AR) family. Finally, excess intracellular 
free fatty acids can disrupt phospholipid bilayer membrane integrity, alter lipid signaling 
pathways, and induce apoptosis [70]. Thus, LSDs provide cells a way of regulating the 
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as for potentially toxic metabolites. 
Lipolysis is the hydrolysis of fatty acyl esters and is the means to which stored 
lipids are mobilized from LSDs [71]. Lipolysis of TAG is needed for energy release ao·d 
is controlled by the activation of Adipose Triglyceride Lipase (A TGL) and Hormone 
Sensitive Lipase (HSL) by protein kinase A (PKA) [72-74]. In addition, intracellular 
lipolysis is tightly regulated by proteins which coat the LSD. These proteins are 
collectively known as the PAT family of proteins, a term first coined by Lu eta/. [75]. 
This family is composed of five proteins (perilipin, adipophilin, tip-47, s3-12 and 
OXPAT) [71]. These proteins all share sequence similarity and the ability to bind lipid 
droplets. These proteins all differ from one another in size, tissue expression, affinity for 
LSDs and transcriptional regulation suggesting that each PAT protein has distinct cellular 
functions [69, 71]. However, each protein contains a highly conserved sequence of 
amino acids called the PAT domain and this domain is the major site of interaction with 
PKA and HSL [71]. The PAT family is evolutionarily ancient and is found in many 
animal species. The conservation of the PAT family throughout evolution helps place 
emphasis on the importance of its role in the regulation of intracellular lipid stores. We 
chose to study genetic variations within two proteins from the PAT family, namely 
perilipin and adipophilin (ADFP) and to determine if there was significant association 
between these variations and obesity phenotypes. 
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Lipolysis m adipocytes is facilitated by three lipases ATGL, HSL and 
monoacylglycerol lipase (MGL). Lipolysis is a tightly regulated process and the current 
understanding is that the process of lipid mobilization from LSDs occurs in a multiple 
step process starting with catecholamine signaling via a P-adrenergic receptor and a G-
protein signaling cascade that elevates intracellular levels of cAMP [71, 76]. Increased 
cAMP levels in turn activate PKA which phosphorylates LSD coating proteins and HSL. 
HSL then translocates from the cytoplasm to the surface of the LSD. It was originally 
thought that the activation and translocation of HSL was the initiation step to lipolysis but 
recent evidence has revealed that a second lipase, A TGL, is the principle lipase in TAG 
lipolysis [77-79]. ATGL is needed for the first step in TAG hydrolysis whereas HSL 
then acts on DAG followed finally by MGL which is required for the final hydrolysis of 
the 2-monoacylglycerol produced by HSL activation [80]. 
Perilipin (PLIN), a hormone regulated phosphoprotein, has been shown to coat 
the outer surface of LSDs [71, 81-82]. PLIN protein is found only in adipocytes and 
steroidogenic cells [83]. In adipocytes, the most abundant LSD coating protein is PLIN. 
PLIN is coded for by the single P LIN locus located on chromosome 15q26, a region 
previously linked to increased susceptibility to obesity and DM2 [71]. PLIN codes for a 
three isoforms of PLIN (perilipin A, B, and C) that arise from translation of alternatively 
spliced mRNA [75, 83]. The protein named Perilipin A is the largest isoform (522 amino 
acids) and the most abundant form found in adipocytes [83-84]. All three PLIN isoforms 
share a common N-terminal region but differ in their C-terminal tails [83]. Perilipin A is 
the most studied isoform of the perilipin family. 
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receptor gamma (PP ARy) and is closely linked to the storage of neutral lipids in 
adipocytes [85]. All three PLIN isofonns are rapidly degraded when not bound to lipid 
droplets [86]. Thus, the mass of the stored neutral lipid acts as a means of post-
translational control of perilipin protein levels in adipocytes. 
Perilipin has 2 roles in triglyceride storage in adipocytes. The first is a protective 
role, where perilipin coats the surface of the LSD thereby stabilizing the neutral lipid 
stored in the LSD. The second is a mobilization role, where perilipin works in concert 
with lipases to release free fatty acids from the LSD. Current theories suggest that by 
coating LSD, perilipin protects them from breakdown until lipolysis is activated [81, 87-
88]. Brasaemle showed that cultured fibroblasts lacking endogenous perilipin increased 
their TAG content by slowing the rate of TAG turnover after addition of ectopic perilipin 
A [88]. In vitro studies in PLIN knockout mice have produced lean mice that were non-
responsive to diet [81]. In addition, perilipin null mice show an elevation of basal 
lipolysis by a factor of 10 and a 75% decrease in adipose tissue when compared to wild 
type animals. Perilipin knockout mice also have a blunted response to catecholamine 
induced lipolysis in their adipocytes [89-90]. New research from Miyoshi et a/. has 
shown that PLIN overexpression in mice protects against diet induced obesity [91]. They 
noted that PLIN overexpression in adipose tissue protected against diet-induced 
adipocyte hypertrophy, obesity and glucose intolerance in transgenic mice suggesting a 
novel role for PLIN in adipose tissue metabolism and regulation of obesity. 
Catecholamine driven activation of lipolysis initiates the PP ARy signaling 
pathway resulting in the activation of PK.A. Perilipin A has six sites for phosphorylation 
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stores but rather assists in their mobilization. Phosphorylated perilipin A also acts as a 
recruiter for HSL resulting in its translocation from the cytosol to the surface of the LSD 
[93]. Sztalryd's lab showed that HSL failed to translocate from the cytosol to the surface 
of LSDs in cells lacking perilipin. They further confirmed the role of perilipin in HSL 
translocation by using CHO fibroblast cells transfected with different forms of perilipin A 
and Green Fluorescent Protein labeled HSL (GFP-HSL). Cells were transfected with wt 
perilipin A, perilipin A with the final 3 PKA phosphorylation sites mutated and with 
perilipin null mutations. The results showed that GFP-HSL translocation only occurred in 
CHO cells expressing fully phophorylatable perilipin A coated LSDs. 
Variations in the PLIN gene have also been associated with numerous 
cardiometabolic risk factor phenotypes. Jang et al. found that fasting plasma free fatty 
acid changes following a modest weight loss in overweight-obese subjects were 
influenced by the genetic variability at the PLIN locus [94]. Moreover, Corella found 
that certain variations in the P LIN gene were more resistant to weight loss than others, 
suggesting that certain polymorphisms may predict outcome of weight loss strategies 
based on low-calorie diets [95]. This was found to be true for different ethnicities as well 
and suggested a possible gender bias towards women [96-98]. In addition, Perez-
Martinez et al. found that the presence of the minor allele in certain PLIN variations was 
significantly associated with lower postprandial TAG levels suggesting a decreased 
atherogenic risk in these individuals over the major allelic variation [99]. 
P LIN variations have been implicated as a factor in insulin resistance as well. 
Corella found evidence of an interaction between dietary fat (specifically saturated fat) 
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determined that a greater intake of energy from saturated fats was associated with 
increased insulin resistance amongst individuals who were homozygous for the rare 
alleles but not individuals who carried the common allele. These interactions were 
observed only in women providing more evidence of a possible gender bias seen with 
P LIN variations. In addition to different effects on obesity associated diseases, PLIN has 
also been implicated as having a role in bone density [101], and in immunohistochemical 
staining for the presence of sebaceous gland carcinoma [ 1 02]. 
Current evidence suggests that genetic polymorphisms in the PLIN gene could 
play a critical role in the etiology of human obesity. Taking this evidence into account, 
our study chose to investigate the effect of three Single Nucleotide Polymorphisms 
(SNPs) in the PLIN gene on obesity phenotypes in a large, healthy, homogeneous 
population from the Canadian province ofNewfoundland and Labrador. 
1.7: Candidate-gene association approach- The adipophilin gene 
Adipose differentiation related protein (ADRP) is a 50 kDa protein first identified 
as an RNA transcript that was significantly induced during differentiation of cultured 
adipocytes in mice models [103-104]. Sequence similarity to perilipin led to the 
discovery that ADRP coats small lipid storage droplets [86]. A human analog was found 
and later renamed adipophilin or ADFP for short [105]. Unlike perilipin, whose 
expression is limited to adipocytes and steroidogenic cells [83], ADFP is expressed in a 
number of different tissue types including early differentiating adipocytes [ 105-1 07]. 
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(FFA) in different cell lines [108-109]. The result after FFA stimulation was an 
upregulation of ADFP mRNA within the cell. This increase in ADFP mRNA occurs in 
conditions in which FF A flux is high, such as fasting in vivo or FF A incubation in vitro. 
However, as adipocyte differentiation progresses and ADFP mRNA levels increase, 
ADFP protein levels decrease [ 1 04, 1 07]. This is in contrast to perilipin, for which both 
its mRNA and protein levels increase as adipocytes mature [107]. During adipocyte 
differentiation perilipin protein replaces the initial ADFP protein coating the LSDs until 
there is no ADFP seen associated with LSDs [86]. This discovery is reinforced by the 
fact that ADFP protein is known to associate with smaller neutral LSDs located within 
most tissues, but rarely in adipose cells that express perilipin [107]. Furthermore, mature 
adipocytes lacking perilipin were found to have significantly smaller LSDs which were 
coated by ADFP. When exogenous perilipin is added to these cells, the ADFP is 
replaced by the perilipin suggesting that perilipin out competes ADFP for the surface of 
the LSD [89, 110-111]. This also suggests that ADFP is ubiquitously expressed in all 
cell lines [ 1 07]. 
ADFP is associated with TAG droplets in non-adipocytes [107]. However, ADFP 
does not offer the same PKA regulation of lipolysis as does perilipin [89] and in fact 
ADFP is not phosphorylated by PKA [89, 93]. Similar to perilipin, any non-LSD bound 
ADFP is quickly degraded [112-113]. Xu eta/., found that protection of ADFP from 
degradation with the proteasome inhibitor MG-132 resulted in a substantial increase in 
lipid content (170%) compared with control cells. This fmding suggested that ADFP, 
like perilipin, protects neutral lipid stores from degradation by lipases [112, 114]. 
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cells due to increased basal lipolysis levels. This suggests that ADFP does not offer the 
same level of protection as does perilipin from basal lipolysis [89, 110-111]. 
The exact role of ADFP in the cell has not yet been determined experimentally. 
Although, it does appear that ADFP protects neutral lipid stores from degradation within 
the cell, it is thought the role of ADFP is more focused towards the accwnulation ofTAG 
stores in LSDs. For example, over-expression of a green fluorescent protein labeled 
ADRP in Swiss-3T3 cells resulted in increased TAG content, even when the cells were 
cultured in non-lipid containing serwn [115]. Also, the presence of ADRP precedes that 
of perilipin during the assembly of LSDs in 3T3 pre-adipocytes [86, 115]. Listenberger 
eta/. found that over expression of ADFP in hwnan embryonic kidney cells resulted in 
increased TAG levels and reduced TAG turnover. They also found that increased ADFP 
production reduced the association of ATGL with LSDs suggesting a further mechanism 
ofhow ADFP protects LSDs from releasing TAG [116]. 
ADFP also has been shown to play a major role in foam cell formation and has 
been described as a possible proathersclergenic protein. Various publications support this 
statement. It has been shown that ADFP expression increases in response to different 
forms of lipid loading in primary hwnan monocytes [117] and in several 
macrophage/monocytic cell lines [118-120]. Beuchler et al. showed that ADFP could be 
induced in macrophage foam cells and that expression increased in response to different 
forms of lipid loading in primary hwnan monocytes. They treated hwnan monocytes 
with enzymatically modified low-density lipoprotein and found they could induce foam 
cell formation in monocytes and upregulate ADFP mRNA and protein within 2 h of 
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free fatty acid. Beuchler et a!. hypothesized that ADFP facilitates the uptake of free fatty 
acids, and the increase in intracellular free fatty acids was related to the early 
upregulation of ADFP expression in serum monocytes [117]. 
Larigauderie et a!. showed that ADFP over expression increased lipid 
accumulation in THP-1 macrophages upon incubation with acetylated LDL, whereas 
depletion of ADFP using small interfering RNA (siRNA) reduced lipid accumulation 
[119]. Furthermore, their analysis of carotid endarterectomy specimens showed that 
ADFP expression was 3.5-fold higher in atherosclerotic plaques than in healthy areas of 
the same artery [ 119]. Analysis of human carotid endarterectomy and coronary artery 
specimens by Wang et al. also demonstrated high ADFP expression and found that it was 
localized mostly in a subset of lipid-rich macrophages [ 121]. Adding to this evidence, 
Chen et a/. found that over expression of adipophilin in macrophages augments 
expression and secretion of proinflanunatory cytokines in macrophages [122]. Lipid 
accumulation and ADFP expression in macrophages positively correlated with one 
another regardless of whether lipid accumulation was being driven by lipid loading or 
whether ADFP levels are being manipulated by over expression or RNA interference and 
in turn this appeared to lead to proinflammatory changes seen in atherosclerotic plaques. 
ADFP has also been implicated as an early marker for the development of DM2. 
Varela recently found that ADFP knockout mice had decreased levels of TAG and 
diacylglycerol in their livers, but fatty acids, long-chain fatty acyl CoAs, ceramides, and 
cholesterol levels were unchanged [123]. They also determined that insulin action was 
enhanced in the livers of these mice, whereas insulin action in muscle and adipose tissue 
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associated with improved insulin sensitivity in humans, specifically weight loss in obese, 
non-diabetic subjects or treatment of DM2 subjects with insulin sensitizers, are associated 
with increased skeletal muscle ADFP protein levels. Phillips et a/. treated nine DM2 
subjects with known insulin sensitizers (troglitazone or metformin) in combination with a 
sulfonylurea (glyburide) for up to 12 weeks. Levels of muscle ADFP in muscle increased 
by 73% after insulin sensitizer treatment in the diabetic cohort and the averaged ADFP 
expression increased 192% over baseline in the weight loss cohort [ 124]. An 
improvement that Phillips correlated to increased levels of ADFP that acted by improving 
the efficiency of lipid storage and lipolytic control. In contrast, Minnard showed that 
rosiglitazone treatment decreased muscle ADFP content in diabetes patients [125]. 
Obviously work is still needed in this field. 
To date there are no published reports of associations between genetic variations 
in the ADFP gene and obesity in humans. Taking into account the evidence that ADFP is 
involved in the production and homeostasis of TAG stores in different cell lines, our 
study chose to investigate the effect of two single nucleotide polymorphisms (SNPs) in 
the ADFP gene on obesity phenotypes in a large, healthy, homogeneous population from 
the Canadian province of Newfoundland and Labrador. 
1.8: The association of abnormal serum lipids with increased serum calcium levels 
An abnormal lipid profile, known as dyslipidemia, is defined as an abnormal reading 
of one or more serum lipid parameters. These parameters include elevated plasma 
cholesterol, LDL-cholesterol (LDL-c) and TAGs or a low HDL-cholesterol (HDL-c) 
level. Primary dyslipidernia refers to the overproduction and/or decreased clearance of 
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several monogenic disorders that lead to different types of dyslipidemias such as familial 
hypercholesterolemia [126-128]. In many cases the etiology is polygenic. Secondary 
dyslipidemias can be defined as mixed elevations of cholesterol and TAG as a response 
to or resulting from an underlying medical condition such as DM2 or hypothyroidism. 
They can also be the result of effects from drug treatments with drugs such as thiazide 
diuretics or from chronic alcohol abuse [129]. These conditions include, but are not 
limited to, DM2, obesity, alcohol overuse, chronic renal insufficiency and/or failure, 
hypothyroidism, liver diseases, rheumatoid arthritis, and pregnancy. Secondary 
dyslipidemias can also be caused by the use of drugs such as thiazides, ~-blockers, 
retinoids and sex hormones [130-135]. Cholesterol and other serum lipids can come from 
the diet as well as be produced by endogenous synthesis and this synthesis occurs mostly 
from ingested fat and sugar. 
A cluster of diseases and syndromes including hypertension, insulin resistance, DM2 
and arthrosclerosis often coexist or overlap in their clinical symptoms [136-140]. Lind et 
al. found that measurements of blood pressure, serum glucose and serum cholesterol were 
all positively associated with each other [141]. However, the specific biochemical 
pathways that are dysregulated and the molecular mechanisms that lead to the 
dysfunction in dyslipidemias, except for those caused by clear genetic and secondary 
conditions, remain unclear. Calcium is a versatile intracellular messenger that is involved 
throughout the life cycle of an organism to control diverse biological processes [142]. It 
has been suggested that diabetes and cardiovascular disease are linked by a common 
defect of divalent cation metabolism, including calcium [143]. 
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produce a given biological response, has been the focus of attention for a common link 
between several clinical disorders with dyslipidernia as one group of the clinical 
manifestation [144-146]. A previous study published by our lab has shown that altered 
serum calcium homeostasis is at least partially responsible for insulin resistance in the 
general population [147]. Data from a Swedish group supported our findings [148]. 
Together, this research helps strengthens the theory that calcium might be the central link 
between dyslipidernia and insulin resistance in hypertension, DM and atherosclerosis. 
Some preliminary association at the population level has been reported in previous 
studies, including the Framingham Heart Study [ 149], where relationships between 
calcium and general biological markers [150], and metabolic syndrome [141] were found. 
However, the general association was not further discussed and left many questions 
unanswered because of the complicated nature of lipid abnormality and serum calcium 
variation. Variations of lipids and serum calcium can be potentially influenced by many 
factors including age, gender, obesity status, medication use, physical activity level and 
other diseases such as DM [130-135]. 
To further investigate the relationship between serum lipids and serum calcium we 
designed a study that would control for major confounding factors such as medications, 
disease status, menopause, parathyroid hormone (PTH) and 25-0H-vitamin D status in 
addition to the common confounding factors of age and gender. 
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2a: Comparison of the classification of obesity by BMI versus dual-energy x-ray 
absorptiometry. 
2a.l: Subjects 
For this study, a total of 1691 adults were recruited from an ongoing large-scale 
nutritional genetics study of human complex diseases called the CODING (Complex 
Diseases in the Newfoundland population: Environment and Genetics) study [151]. 
Subjects were recruited from the province ofNewfoundland and Labrador (NL), Canada, 
by means of poster distribution and person-to-person contact. Subjects who met the 
following criteria were eligible to participate in the study: 1) aged 19 or older; 2) at least 
third generation Newfoundlander; 3) healthy, without any serious metabolic, 
cardiovascular, or endocrine disease and ( 4) not pregnant at the time of the study. All 
subjects provided written consent and completed questionnaires pertaining to their 
demographic background, health status, and family history. The Research Ethics Board 
of the Faculty of Medicine, Memorial University of Newfoundland, approved the study 
prior to commencement. 
2a.2: Study design 
This study investigated differences between BMI-determined adiposity status and 
DXA to evaluate the accuracy of BMI. The objectives of our study were as follows: 1) 
Determine the accuracy of BMI classifications compared to %BF classifications 
measured by DXA; 2) Determine if discrepancies between BMI and DXA are gender-
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aad. agi s~eeifie· l-) Iaefttif} whethet an individaa:l's cmrem arttpostty status (t.e. 
overweight or obese) can affect the size of error in their BMI. 
2a.2.1: Body composition measurements 
Subjects were weighed, and their heights were measured, wearing standardized 
light gowns, without shoes, on a platform manual scale balance (Health o meter Inc., 
Bridgeview, IL, USA). Whole-body composition measurements, including %BF, trunk 
fat percentage (%TF), lower body (legs) fat percentage (%LF), lean body mass, and bone 
mineral densities were determined using dual-energy X-ray absorptiometry (DXA) by 
Lunar Prodigy (GE Medical Systems, Madison, WI, USA). Measurements were 
performed on subjects, following the removal of all accessories containing metal, while 
lying in a supine position. Software version 4.0 was used for analysis. 
2a.3: Statistical analysis 
Prior to data analysis, all subjects were classified according to adiposity status 
using both BMI and %BF criteria. Subjects were classified using BMI as underweight 
(UW; < 18.5 kg-m-2), normal weight (NW; 18.5 - 24.9 kg-m-2), overweight (OW; 25.0 -
29.9 kgm-2) , or obese (OB; > 30.0 kg-m-2) according to criteria of the World Health 
Organization [3]. Subjects were grouped according to %BF based on criteria 
recommended by Bray that is both age and gender specific (Table 1.1) [30]. Differences 
in physical characteristics between men and women were assessed using Student's t-test. 
Differences in body weight classification between BMI and DXA were analyzed on the 
fo llowing three levels: 
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Men and women were separated into weight classifications according to SMI 
and %SF criteria. The number of subjects grouped into each weight category by 
both methods was calculated as a percentage of the total number of participants. 
Differences in percentages between SMI- and %SF-defined adiposity status 
were analyzed within gender using Chi-Square analyses. 
2. Discrepancy analysis by age group. 
SMI-defined weight classifications were compared to %SF criteria among 
different age groups to investigate the effect of age on SMI accuracy. Women 
were separated into four groups according to their age (20-29.9, 30-39.9, 40-
49.9, 50+) and differences in percentages between SMI- and %SF-defined 
adiposity status were analyzed using Chi-Square analyses. Due to the small 
number of men in our cohort, similar analysis in males could not be performed 
as the number of subjects in each cell (four age groups by four weight groups) 
was too small for effective comparison. 
3. Ranges of percent body fat based on SMI cutoffs. 
In order to study the range of %SF found in each SMI category, subjects were 
grouped by SMI into adiposity groups and then %SF averages for each SMI 
group were calculated along with minimum and maximum values. 
SPSS version 14.0 (SPSS Inc., Chicago, IL) was used for all analyses. Statistical 
analyses were two-sided and a p value < 0.05 was considered to be statistically 
significant. 
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2b: Association between serum lipids and serum calcium levels. 
2b.l Subjects 
For this study, a total of 1907 adults were recruited from an ongoing large-scale 
nutritional genetics study of human complex diseases called the CODING (Complex 
Diseases in the Newfoundland population: Environment and Genetics) study [ 151]. 
Subjects were recruited from the province ofNewfoundland and Labrador (NL), Canada, 
by means of poster distribution and person-to-person contact. Subjects who met the 
following criteria were eligible to participate in the study: 1) aged 19 or older; 2) at least 
third generation Newfoundlander; 3) healthy, without any serious metabolic, 
cardiovascular, or endocrine disease and (4) not pregnant at the time of the study. All 
subjects provided written consent and completed questionnaires pertaining to their 
demographic background, health status, and family history. BMI was calculated as body 
weight (kg) divided by height (m) squared. Subjects who self-reported having DM or 
who had fasting glucose levels ?:.7.0 mmol/L were designated as having DM. The 
Research Ethics Board of the Facu1ty of Medicine, Memorial University of 
Newfoundland, approved the study prior to commencement. 
2b.2: Biochemical measurements 
Blood samples were obtained from all subjects after they had fasted for 12 h. 
Serum concentrations of total calcium, phosphorus, magnesium, triglycerides, total 
cholesterol, and HDL-c were measured. Additionally, glucose and albumin were 
measured using Synchron reagents performed on an LX20 clinical chemistry analyzer 
(Beckman Coulter, Fullerton, CA). Serum total calcium concentration was corrected by 
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LDL-c was calculated by using the following formula: cholesterol - H D Lc -
( trig lycerides). 2.2 The LDL-c calculation is reliable in the absence of ·severe 
hyperlipidemia. Serum parathyroid hormone (PTH) and insulin were measured on an 
lmmulite immunoassay analyzer using the IMMULITE 1000 Intact PTH kit (Diagnostic 
Products Corporation, Los Angeles, CA). 25-0H-vitarnin D was measured using a 25-
Hydroxyvitamin D 125 I RIA Kit (DiaSorin, Stillwater, MN). Homeostasis model 
assessment was used to estimate insulin resistance and ~-cell function [152]. 
2b.3: Measurement of body composition 
Subjects were weighed, and their heights were measured, wearing standardized 
light gowns, without shoes, on a platform manual scale balance (Health o meter Inc., 
Bridgeview, IL, USA). Whole-body composition measurements, including %BF, trunk 
fat percentage (%TF), lower body (legs) fat percentage (%LF), lean body mass, and bone 
mineral densities were determined using dual-energy X-ray absorptiometry (DXA) by 
Lunar Prodigy (GE Medical Systems, Madison, WI, USA). Measurements were 
performed on subjects, following the removal of all accessories containing metal, while 
lying in a supine position. ENCORE 2002 software version 6.70 was used for analysis. 
2b.4: Statistical analysis 
Data are presented as means± SD. The analyses consist of the following parts: 
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and the levels of total cholesterol, TAG, HDL-c and LDL-c within sex after 
controlling for the confounding variables. 
2. Partial correlations were repeated according to medication use and menopausal 
status (pre- and post-menopausal women), within group with or without 
medication use, and within each group of pre- or post-menopausal women. 
3. In one-way ANOVA analyses, adjustments for the effects of covariates on serum 
calcium, cholesterol, TAG, HDL-c and LDL-c were carried out using a linear 
regression procedure. The covariates for serum calcium and lipids were age, 
phosphorus, and magnesium; percent trunk fat was also included as a covariate in 
the analyses for serum lipids. The results from one-way ANOVA were corrected 
by the TUKEY method. 
4. To account for the influences of vitamin D and PTH, subjects from the 
"medication-free" group were ranked according to serum calcium concentration; 
100 women (top 50 and bottom 50) were selected, and the serum concentrations 
of 25-0H vitamin D and PTH were measured. Total serum calcium levels were 
adjusted for the concentrations of 25-0H vitamin D and PTH using a linear 
regression model before analysis. The levels of total cholesterol, TAG, HDL-c 
and LDL-c were then compared between the low and high calcium groups using a 
student t test. All analyses were performed using the SPSS software for Windows, 
version 15.0. 
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Of all the confounding factors considered in this study, the use of medications is 
probably the biggest factor that modifies serum lipids either primarily by treating 
dyslipidernia or secondarily through other medical processes such as hormone 
replacement therapy in women. In addition to serum calcium, evidence from both human 
and animal experiments show that magnesium may exert influence on lipid metabolism 
[153-156]. Obesity status is the most prominent risk factor contributing to metabolic 
syndrome and lipid abnormalities, especially central obesity [130, 157]. Trunk fat 
percentage was found to be more significantly associated with lipids in our primary 
analysis using Pearson correlation than other measures of body composition. Therefore, 
we chose trunk fat percentage as the covariate representing body composition. 
2c: Genetic association study - Roles of Perilipin and Adipophilin on obesity 
phenotypes 
2c.l: Subjects 
For this study, a total of 1273 adults were recruited from an ongoing large-scale 
nutritional genetics study of human complex diseases called the CODfNG (Complex 
Diseases in the Newfoundland population: Environment and Genetics) study [ 151]. 
Subjects were recruited from the province ofNewfoundland and Labrador (NL), Canada, 
by means of poster distribution and person-to-person contact. Subjects who met the 
following criteria were eligible to participate in the study: (1) aged 19 years or older, (2) 
at least third generation Newfoundlander, (3) healthy, without any serious metabolic, 
cardiovascular or endocrine diseases, and (4) not pregnant at the time of the study. All 
subjects provided written consent and completed questionnaires pertaining to their 
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of the Faculty of Medicine, Memorial University of Newfoundland, approved the study 
prior to commencement. 
2c.2: Study design 
This study was a candidate-gene association study on a large NL based cohort. 
All measurements and blood samplings were performed in the morning following a 12-
hour fast. 
2c.2.1: Blood samples 
For plasma isolation, blood was collected in evacuated tubes containing K3EDTA 
as an anti-coagulant. Tubes were immediately centrifuged at 4 °C for 15 minutes at 
1300g. Plasma was removed and stored at -80 °C until further analysis. For serum 
isolation, blood was collected in tubes containing a clot activator. Tubes were allowed to 
sit at room temperature for 20 minutes, followed by centrifugation at 25 °C for 1 0 
minutes at 3500 rpm. Serum was removed and stored at -80 °C until further analysis. 
2c.2.2: Body composition measurements 
Subjects were weighed, and their heights were measured, wearing standardized 
light gowns, without shoes, on a platform manual scale balance (Health o meter Inc., 
Bridgeview, IL, USA). Whole-body composition measurements, including %BF, trunk 
fat percentage (%TF), lower body (legs) fat percentage (%LF), lean body mass, and bone 
mineral densities were determined using dual-energy X-ray absorptiometry (DXA) by 
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performed on subjects, following the removal of all accessories containing metal, while I 
lying in a supine position. Software version 4.0 was used for analysis. Classification for 
lean and obese were as follows: obese for females aged 20-39 years was classified as::: 
39% body fat (lean as < 33%) and aged 40-59 years was classified as ::: 41% (lean as < 
35%); obese for males aged 20-39 years was classified as::: 26% body fat (lean as< 21 %) 
and aged 40-59 years was classified as::: 29% (lean as< 23%) (Table 1) [30]. 
2c.2.3: Biochemical measurements 
Serum concentrations of glucose, total cholesterol, HDL-C, and TAGs were 
measured using Synchron reagents performed on an Lx20 (Beckman Coulter, Inc., CA, 
USA) by Dr. Edward Randell in the discipline of Laboratory Medicine. Serum insulin 
levels were measured on an Immulite immunoassay analyzer (DPC, CA, USA). LDL-C 
was determined using the following equation: [total cholesterol- HDL-C- (TAGs/ 2.2)], 
and risk factor was determined using the equation: (total cholesterol/HDL-C). 
2c.2.4: Genomic DNA extraction and genotyping 
Genomic DNA was extracted from whole blood (5ml) using the Wizard® 
Genomic DNA purification kit (Promega, Madison, WI, USA) according to the 
manufacturer's protocol. This kit is designed for the isolation of DNA from white blood 
cells. The protocol can be summarized in four main steps. Firstly, red blood cells were 
lysed in the Cell Lysis Solution and removed. Secondly, white blood cells and their 
nuclei were lysed in the Nuclei Lysis Solution. Thirdly, cellular proteins were removed 
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was concentrated and desalted by an isopropanol precipitation. 
Genotyping was performed using the TaqMan® validated SNP Genotyping 
Assays (Applied Biosystems, CA, USA) according to the manufacturer's protocol. Each 
assay required polymerase chain reaction (PCR) amplification and allelic discrimination 
plate read and analysis. PCR amplification required four components: 
1) purified genomic DNA (20ng). 
2) 20X SNP Genotyping Assay Mix (0.75!-ll), which contained sequence-specific forward 
and reverse primers to amplify the desired SNP and two TaqMan® minor groove binder 
(MGB) probes. Each probe had a reporter dye attached to its 5' end and a nonfluorescent 
quencher (NFQ) to its 3' end (Figure 2.1). One probe was labeled with VIC dye and 
detected the Allele 1 sequence and the other probe was labeled with F AM dye and 
detected the Allele 2 sequence. 
3) 2X TaqMan® Universal PCR Master Mix, No AmpErase® Uracil-N-Glycosylase 
(UNG) (7.5!-ll), which contained AmpliTaq Gold® DNA polymerase and other 
components required for the PCR reaction, such as deoxynucleotides and magnesium 
chloride. 
4) DNAse, RNAse Free, distilled water (2.75!-ll). 
The PCR reaction was performed on an Eppendorf Mastercycler and consisted of five 
steps: 1) 2 minutes at 50°C, 2) 10 minutes at 95 °C, 3) 15 seconds at 95 °C, 4) 1 minute at 
60 °C, 5) 40 cycles of steps 3-4. During the PCR reaction, each probe bound to a 
complementary sequence between the forward and reverse primers, and the proximity of 
the reporter dye to the quencher resulted in suppression of the reporter fluorescence. The 
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target, thereby separating the reporter dye from the quencher. This resulting in an 
increase in fluorescence by the reporter. Following PCR amplification, allelic 
discrimination and analysis was performed using an ABI Prism 7000'lil sequence detection 
system (SDS). The SDS software calculated the fluorescence measurements from the 
plate read and created a plot of the signals. If there was a substantial increase in the VIC 
dye fluorescence only, it indicated that the sample was homozygous for allele 1. If there 
was a substantial increase in the F AM dye fluorescence only, it indicated that the sample 
was homozygous for allele 2. If there was a substantial increase in both fluorescent 
signals, it indicated heterozygosity for allele 1 and allele 2 (Figure 2.2). 
To evaluate the quality of genotyping, 5% of the samples were randomly selected 
and re-genotyped. A total of 4011 SNP genotyping assays (3 SNPs x 1273 subjects + 5% 
verification) were completed. 
2c.3: Candidate gene- Perilipin. 
The three SNPs in the P LIN gene that were investigated were an N C 
polymorphism located in the 3' untranslated region (public ID, dbSNP:rs4932241; public 
location: Chromosome 15 - 88005658), an NG SNP located between the 6th and 7th 
exon (public ID, dbSNP: rs894160; public location: Chromosome 15 - 88012827) and an 
NG SNP located between the 2"d and 3rd exon (public ID, dbSNP: rs2289487; public 
location: Chromosome 15 - 880181 00) (Figure 2.3). 
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Figure 2.1: Illustration of the TaqMan minor groove binder probe with a reporter dye 
attached to its 5' end and a non-fluorescent quencher attached to its 3' end (adapted from 
ABI Assays-on-Demand Gene Expression Products Protocol). 
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Figure 2.2: An example of an allelic discrimination showing 4 distinct groups: grey 
squares refer to non-template controls; blue diamonds refer to homozygosity for allele Y; 
green triangles refer to heterozygosity; red circles refer to homozygosity for allele X. 
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The two SNPs in the ADFP gene that were investigated were an A/G 
polymorphism located in the 5' UTR (public ID, dbSNP: rs3824369; public location: 
Chromosome 9 - 19,116,565), and an A/G SNP located in the 3' untranslated region 
(public ID, dbSNP: rs35629534; public location: Chromosome 9 -19,105,720) (Figure 
2.4). 
2c.5: Statistical analysis 
All statistical analyses were performed using the statistical software R or SPSS 
software version 16 for Windows; with significance set at p<0.05. Hardy-Weinberg 
equilibrium was tested using chi-square analysis. Chi-square analysis was also used to 
assess the allele differences between obese and non-obese subjects for each of the SNPs 
investigated. One-way ANOVA, corrected with Bonferroni t-test, was used to assess 
differences among genotype groups of SNPs with body compositions (%BF, % TF, %LF, 
and BMI) in males and females. Analyses were repeated after adjusting %BF, %TF, 
%LF, and BMI for gender and age. One-way ANOVA, corrected with Bonferroni t-test, 
was also used to assess differences among genotype groups of SNPs with serum lipid 
parameters in males and females. Due to the skewed distributions, the TAG parameters 
were transformed using log10 prior to data analysis. Similarly, analyses were repeated 
after adjusting serum lipid parameters for age and %BF. 
Page 50 of 106 
AJG AJG AJC 
l 
3' 
Figure 2.3: Approximate locations ofthe 3 SNPs investigated within the PLIN gene. 
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Figure 2.4: Approximate locations of the 2 SNPs investigated within the ADFP gene. 
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3a: Comparison of the classification of obesity by BMI versus dual-energy x-ray 
absorptiometry. 
3a.1: Subjects 
Physical characteristics for female and male participants are shown in Table 3.1. 
The age range for all subjects ranged from 20-84 years old. Male subjects were 3.5 years 
younger than women on average. Men were also 16.4 kg heavier and 13.4 em taller 
compared to women and had BMI measurements 1.5 units higher which reflects averages 
seen in similar studies [158]. Men also had greater waist-to-hip ratios and lower %BF 
and trunk fat percentage (% TF) compared to women. 
3a.2: General discrepancy analyses by gender 
Significant discrepancies between BMI and %BF criteria were identified in both 
women and men. Of the 1321 women included in our study, BMI classified 44.4% (584) 
as NW while DXA classified only 29.7% (391) as NW (Figure 3.1). Classification of 
OW women was similar between the two methods (BMI 34.1 % ( 452), DXA 31.0% 
(408)). Among OB women there was again a large discrepancy between the two 
methods. According to BMI criteria, 20.3% (269) of women in our cohort were obese 
however according to %BF criteria 37.1% (493) of women were obese. As a result, BMI 
classified 14.7% more women as normal weight and 16.8% less women as obese 
compared to %BF criteria determined by DXA (p<O.OO l). A total discrepancy of 42.2% 
was found between the two methods in women. 
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Table 3.1: Physical characteristics of female and male subjects (n = 1691)1• 
Variables Women Men 
n = 1321 n = 370 
Age (yrs) 44.1 ± 10.8 (20, 84) 40.4 ± 13.8 (20, 76) 
Weight (kg) 68.7 ± 14.1 (38.8, 156.8) 84.4 ± 13.9 (53.5, 148.4) 
Height (em) 162.1 ± 5.8 (135.0, 186.7) 175.6 ± 6.6 (157.0, 198.1) 
BMI (kg m-2) 26.5 ± 5.2 (16.0, 54.3) 27.6 ± 4.5 (16.8, 50.4) 
Waist (em) 90.6 ± 14.3 (62.7, 168.0) 97.8 ± 12.2 (63.7, 148.8) 
Hip (em) 102.5 ± 11.6 (76.5, 172.0) 101.3 ± 9.1 (69.0, 145.1) 
Waist-to-hip ratio 0.88 ± 0.07 (0.64, 1.24) 0.96 ± 0.06 (0.74, 1.20) 
Body fat(%) 37.6 ± 7.4 (4.6, 59.9) 23.5 ± 7.5 (5.6, 47.6) 
Trunk fat(%) 38.8 ± 8.6 (3.9, 64.3) 30.0 ± 8.8 (4.7, 53.1) 
1 All values are mean ±SD; minimum and maximum values are in parentheses. 
2 Significantly different from men according to Student' s t-test (p<O.OOI). 
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t-test 
p value2 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
Of the 370 men included in this study, BMI and %BF classifications were similar 
for NW individuals (BMI 29.8%, DXA 32.2%; Figure 3.2). Among OW and OB men, 
significant differences were evident in weight classification among the two methods. 
BMI categorized 45.3% of men as OW and 24.3% as OB while DXA classified only 
28.3% of men as OW and 37.7% as OB. BMI classitied 17% more men as OW and 
13.4% less men as obese compared to %BF criteria based on DXA measurements 
(p<O.OO 1 ). A total discrepancy of 30.4% was evident between the two methods in men. 
3a.3: Discrepancy analyses by age group 
After separation of the female cohort into groups based on age, similar 
discrepancies were evident between BMI- and %BF-defined adiposity status across all 
four age groups (Table 3.2). There was a significant discrepancy between the two 
methods for NW and OB women across all age groups (p < 0.001). The discrepancy 
between BMI and DXA-determined %BF ranged from 12% to 19% for NW women and 
13% to 23% for OB women. Women in their 30s demonstrated the largest discrepancy 
between BMI and %BF for both NW and OB groups. Women in their 40s demonstrated 
the smallest discrepancy between the two methods among the four age groups. The 
discrepancies found in the female cohort for UW and 0 W BMI classifications compared 
to %BF were not significant for all age groupings. Males were not analyzed by age group 
due to small sample size. 
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Figure 3.1: Comparison ofBMI- and DXA-defined weight classifications in women 
according to body size (n = 1321). 
* p < 0.00 I for difference between the two methods according to Chi Square analyses. 
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Figure 3.2: Comparison ofBMI- and DXA-defined weight classifications in men 
according to body size (n = 370). 
• p < 0.00 I for difference between the two methods according to Chi Square analyses. 
Page 56 of 106 
Table 3.2. Percent disetepmtcies between BMI mtd OXA: wetgf'l.t classtfications m 
women according to age {n = 1321 t 
Age Group 
2~29.9 30-39.9 4~49.9 50+ Overall 
n = 164 n =204 n = 51 3 n = -140 n = 1321 
BMJ DXA % 01 BMJ DXA %0 BMJ DXA % 0 BMJ DXA % 0 BMJ DXA % 0 
oderweight 4 9 -3 4 3 +I 5 13 -2 3 4 0 16 29 -I 
Normal weight 100 69 +19* 100 63 + 19* 214 155 + 12* 170 104 + IS* 59 1 395 + IS* 
Overweight 43 35 +5 64 56 +4 187 170 +3 158 147 +3 453 4 12 +I 
Obese 17 5 1 -21* 36 82 -23* 107 175 - 13* 109 185 -17* 270 494 -17* 
1 BMl and DXA values are raw numbers of women classified into each adiposity group. 
2 %0 , Percent discrepancy between BMl- and DXA-defined weight classification; calculated as percentage 
of women grouped into 
BMI category subtracted from percentage of women grouped into DXA category. 
*Significant difference between BMI- and DXA-defmed weight classification according to Chi Square 
analyses (p < 0.001). 
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Figure 3.3: Percentage body fat (%BF) variations among women and men according to BMI 
classification. 
%BF, percentage body fat; UW, underweight; NW, normal weight; OW, overweight; Ob, obese. 
Data is presented as mean and minimum/maximum values for %BF. 
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The variation in %BF according to BMI categories for men and women is found 
in Figure 3.3. A large range of error indexed by %BF was found in each BMI category 
for both genders. A total of224 OB women (determined by DXA) were misclassified as 
either NW or OW by BMI criteria. There was a wide range in %BF for NW and OW 
women (4.6- 51.1% and 14.8 - 51.8%, respectively). OW women (DXA) were also 
misclassified as UW and NW according to BMI criteria. In addition, NW and UW 
women (DXA) were misclassified as OW and NW, respectively. This suggests that BMI 
misclassifies female subjects across all four weight classifications. The data among men 
was similar. A total of 50 OB men (determined by DXA) were misclassified as NW or 
OW according to BMI criteria. The range in %BF for NW and OW men was 5.6 - 31.2 
% and 10.8 - 41.3%, respectively. Although the misclassifications were bi-directional, 
BMI tended to under-classify subjects for the majority of individuals. 
Page 58 of 106 
calcium levels. 
3b.l: Subjects 
The physical characteristics and biochemical measurements of the adult population 
studied are shown in Table 3.3. There are significant differences between women and 
men in all physical characteristics and biochemical markers except for total serum 
calcium concentration corrected for serum albumin (serum Ca++-C), Mg++ and LDL-c. 
3b.2: Partial correlations between serum Ca ++ -C concentration and lipids 
The results of the partial correlations between serum Ca ++ -C and lipid markers based 
on gender are shown in Table 3.4. Significant positive correlations of serum total 
cholesterol, TAG, HDL-c and LDL-c with serum Ca ++ -C were found in women (r = 0.26, 
r = 0.16, r = 0.11 and r = 0.19, respectively; p <0.0001 for all variables). Significant 
correlations between serum Ca++-C and serum total cholesterol, HDL-c and LDL-c were 
also observed for men (r = 0.13, r = 0.12 and r = 0.10, respectively; p =0.05 to 0.009). 
Women and men not taking any medication were analyzed using partial correlation, 
controlling for age, trunk fat, phosphorus and magnesium (Table 3.5). The significant 
positive correlations remained between serum Ca ++ -C and lipids in women, but the 
significant HDL-c correlation was lost in men. 
Women were further categorized into pre- and post-menopausal groups for analyses 
in Table 3.6. The significant positive correlations between serum Ca ++ -C and all four 
lipid markers remained in both pre- and post-menopausal women groups. 
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Females (n=1383 -1472) 
Age (years) 44.7 ± 11.3 (19 -84) 
Weight (kg) 69.6 ± 14.1 (39.5 -156.8) 
Height (em) 162.1 ± 5.8 (135.0 -186.7) 
BMI (kg/m 2) 26.5 ± 5.3 (16.0 -54.3) 
Waist circumference (em) 90.9 ± 14.4 (54 -168) 
%FAT 37.8 ± 7.5 (4.6 -60.2) 
%FAT -Tnmk 38.9 ± 8.8 (3.9 -65.3) 
Lean body mass (kg) 39.7 ± 5.5 (25.8 -81.9) 
++ Serum Ca (mmol/L) 2.34 ± 0.12 (1.72-3.01) 
Serum Ca ++_C (mmol/L) *1'*2 2.33 ± 0.11 (1.67 -2.92) 
Serum Phosphorus (rnmol/L) 1.21 ± 0.17 (0.69 -1.97) 
++ I Serum Mg (mmol/L)* 0.88 ± 0.08 (0.47 -1.48) 
Cholesterol (mmol/L) 5.21 ± 1.03 (2.40 -9.98) 
Triglyceride (mmo l/L) 1.15 ± 0.70 (0.23 -5.88) 
HDL-cholesterol (mmol/L) 1.56 ± 0.38 (0.77 -3.25) 
I LDL-cholesterol (mmol/L) * 3.12 ± 0.89 (0.65 -7.61) 
Risk factor 3.48 ± 0.95 (0.68 -8.41) 
Data are means± SO; 
Males (n=422 -435) 
41.0 ± 13.3 (19 -82) 
85.0 ± 14.2 (53 .6 -149.4) 
175.7 ±6.3 (157 -198) 
27.6 ± 4.4 (16.8 -50.4) 
97.9 ± 11.9 (64 -149) 
25.3 ± 7.5 (5 .6 -48.0) 
30.0 ± 8.8 (4.7 -53.0) 
59.5 ± 7.5 (37.2 -100.5) 
2.36 ± 0.12 (1.76 -2.81) 
2.32 ± 0.10 (1.91 -2.68) 
1.13 ± 0.18 (0.65 -1.66) 
0.89 ± 0.11 (0.11 -1.85) 
5.02 ± 0.97 (2.82 -6.97) 
1.24 ± 0.71 (0.35 -3.75) 
1.40 ± 0.36 (0.65 -2.34) 
3.06 ± 0.84 (1.3 1 -5.00) 
4.22 ± 1.16 (2.08 -8.51) 
*
1 p value < 0.05-0.001 for all variables, except for serum Ca++-C, Mg++ and LDL-cholesterol in the comparison between 
women and men using Student's t-test; 
*
2 Calcium-C means total serum calcium corrected by albumin (Ca+O.l x (40-albumin)/6). 
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Table 3.4: Partial correlations between serum Ca++-C concentration and lipids. 
Females Males 
(n=l373) (n=382) 
Parameter r p r p 
Cholesterol (rnrnol/L) 0.26 <0.0001 0. 13 0.00 9 
Triglyceride (mmol/L) 0.1 6 <0.0001 0.05 ns 
HDL (rnrnol/L) 0.1 1 <0.0001 0.1 2 0.0 16 
LDL (rnrnol!L) 0.19 <0.0001 0.10 0.05 
Confounding factors including age, trunk fat percentage, phosphorus and magnesium were 
correspondingly controlled in analyses where applicable. 
Table 3.5: Partial correlations between serum Ca ++ -C concentration and lipids in subjects without 
taking any medication. 
Females Males 
(n 595) (n=236) 
Parameter r p r p 
Cholesterol (mmoVL) 0.24 <0.0001 0.19 0.004 
Triglyceride (mmol/L) 0.09 0.028 0.12 0.056 
HDL (mmol/L) 0.12 0.005 0.10 ns 
LDL (mmol/L) 0.19 <0.0001 0.16 0.015 
Confounding factors including age, trunk fat percentage, phosphorus and magnesium were 
correspondingly controlled in analyses where applicable. 
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in pre- and post-menopausal women. 
Pre-menopausal Post-menopausal 
(n=763) (n=595) 
Parameter r p r p 
Cholesterol (mmol/L) 0.31 <0.0001 0.24 <0.0001 
Triglyceride (mmol/L) 0.16 <0.0001 0.09 <0.05 
HDL (mmol/L) 0.17 <0.0001 0.12 0.005 
LDL (mmol/L) 0.21 <0.0001 0.19 <0.0001 
Confounding factors including age, trunk fat percentage, phosphorus and magnesium 
were correspondingly controlled in analyses where applicable. 
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Table 3. 7: Levels of serum cholesterol, TAG, HDL-c and LDL-c amon low medi 
- groups. 
Calcium group Women Men 
n=l378-1381 n=386-389 
Cholesterol (mmol/l) L 4.97 ± 0.88 5.01 ± 1.03 
M 5.10 ± 1.02 5.11±1.13 
H 5.56 ± 1.09 5.17±1.22 
P value <0.0001 * ns 
TAG (mmol/L) L 1.03 ± 0.61 1.80 ± 0.91 
M 1.07 ± 0.61 1.54 ± 1.08 
H 1.32 ± 0.83 1.48 ± 1.11 
P value <0.0001 *1 ns 
HDL-c (mmol/L) L 1.53 ± 0.35 1.20 ± 0.24 
M 1.56 ± 0.37 1.22 ± 0.27 
H 1.60 ± 0.41 1.28 ± 0.28 
P value 0.017*2 <0.05*2 
LDL-c (mmol/L) L 2.96 ± 0.78 3.13 ± 0.88 
M 3.06 ± 0.88 3.19± 0.95 
H 3.36 ± 0.94 3.22 ± 0.94 
P value <0.0001 *1 ns 
Data are means± SD. Significance assessed by one-way ANOVA, corrected by TUKEY 
method. * Significance between any two groups; * 1 Significance between L vs H, and M 
vs H; *2 Significance between L vs H. L= low calcium group; M=medium calcium group; 
H= high calcium group. 
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HDL-c and LDL-c 
The levels of serum lipids in female and male subjects according to the 
concentrations of serum Ca++-C are shown in (Table 3.7). In women, those in the low 
serum Ca++-C group had the lowest fasting total cholesterol, HDL-c and LDL-c levels, 
those in the medium serum Ca ++ -C group had an intermediate total cholesterol, HDL-c 
and LDL-c levels, and those in the high calcium group had the highest total cholesterol, 
TAG, HDL-c and LDL-c levels, (P <0.0001 for all four variables). The only significant 
difference between calcium groups found in men was with HDL-c. 
Moreover, the effects of 25-0H vitamin D and PTH were adjusted in a selected group 
of 100 women (Table 3.8). Subjects with low serum Ca ++ -C concentrations had a 
significantly lower level of fasting total cholesterol, TAG and LDL-c compared with 
subjects with high calcium concentration (P <0.0001, =0.015 and =0.004, respectively). 
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Table 3.8t CemJ'Mi~on~ of lipids between low and h1gh ca:tctum groups adJusted for 25-
OH vitamin D and PTH in female subjects. 
Low calcium group High calcium group p 
(n=50) (n=50) 
Cholesterol (mmol/L) 4.83 ± 0.12 5.83±0.17 <0.0001 
TAG (mmol/L) 0.97 ± 0.08 1.40±0.13 0.015 
HDL-c (mmol/L) 1.54 ± 0.05 1.67 ± 0.06 ns 
LDL-c (mmol/L) 2.85 ± 0.10 3.53 ± 0.15 0.004 
Student t-test. Values are shown in mean ± SE of raw values. Before analysis, total serum calcium was 
adjusted for 25-0H vitamin D and PTH, serum cholesterol, TAG, HDL-c and LDL-c for age and %trunk 
fat using linear regression analysis. 
Table 3.9: Demographic and body composition data for all subjects. (n= 1269) 
Female Male Overall t-test 
(n=1002) (n=267) (n=1269) (p-value) 
Age (y) 43 ± 10.0 (19, 62) 39.8 ± 12.7 (19, 61) 42.2 ± 10.7(19, 62) <0.0001 
Weight (Kg) 69.1 ± 13.8 (45.4, 157) 85.1 ± 15.0 (53.6, 149.4) 72.5 ± 15.5 (45.4, 156.8) <0.0001 
Height (em) 162. ± 5.9 (135, 191) 175.2±6.6(157, 198) 164.9 ± 8.1 (135, 198) <0.0001 
BMI (Kg!m2) 26.3 ± 5.1 (17, 54.3) 27.8 ± 4.7 (16.8, 50.4) 26.6 ± 5.0 (16.8, 54.3) <0.0001 
Waist (em) 90.1 ± 13.9 (63.6, 168) 98.1 ± 12.5 (63 .7, 148.8) 91.8 ± 14.0 (63.6, 168) <0.0001 
Hip (em) 102 ± 11.3 (76.5, 172) 101.5 ± 9.4 (76.5, 145.1) 102.1 ± 10.9 (76.5, 172) <0.0001 
WIR Ratio 0.88 ± 0.07 (0.6, 1.2) 0.97 ± 0.06 (0.74, 1.2) 0.90 ± 0.08 (0.6, 1.2) <0.0001 
%BF 37.3 ± 7.1 (4.6, 59.9) 25.7 ± 7.4 (7.4, 47.6) 34.9 ± 8.6 (4.6, 59.9) <0.0001 
%TF 38.4 ± 8.2 (3 .9, 64.3) 30.4 ± 8.5 (8.7, 53.1) 36.7 ± 8.9 (3.9, 64.3) <0.0001 
Cholesterol 5.25 ± 1.0 (2.3, I 0) 5.09 ± 1.1 (2.8, 9.2) 5.2 1 ± 1.0 (2.3 , 10) <0.0001 
HDL-e 1.58 ± 0.36 (0.8, 3.3) 1.26 ± 0.25 (0.7, 2.2) 1.51 ± 0.36 (0.7, 3.3) <0.0001 
LDL-e 3.13 ± 0.89 (0.7, 7.6) 3.15 ± 0.87 (0.7, 5.7) 3.13 ± 0.89 (0. 7, 7.6) <0.0001 
TG 1.17 ± 0.73 (0.2, 5.9) 1.50 ± 1.0 (0.3, 5.0) 1.24 ± 0.8 (0.2, 5.9) <0.000 1 
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phenotypes. 
3c.l: Subjects 
The physical and biochemical characteristics of the subjects are shown in Table 
3.9. There were 1269 eligible subjects (1002 females and 267 males). The subjects' ages 
ranged from 19-62 years old. Male subjects were 3.2 years younger than women on 
average. Men were also 16 kg heavier, 13.2 em taller, had BMI measurements 1.5 units 
higher and had higher serum cholesterol and TAG measures, and waist-to-hip ratios 
greater that the female cohort. Women had greater %BF and trunk fat percentage (%TF), 
higher serum HDL-c and total serum cholesterol compared to men. These population 
characteristics reflect averages seen in similar studies [ 15 8]. 
A summary of the 5 SNPs investigated including allele frequencies, allelic 
variation and location are presented in Table 3.10. SNPs rs4932241 (3 'UTR), rs894160 
(between exon 6 and 7) and rs2289487 (between exon 2 and 3) are located in the perilipin 
coding region on chromosome 15. The frequencies for alleles A and C of the SNP 
rs4932241 were 0.69 and 0.31 , frequencies for alleles A and G for the SNP rs894160 
were 0.74 and 0.26, and frequencies for alleles A and G of the SNP rs2289487 were 0.68 
and 0.32, respectively (Table 3.10A). 
SNPs rs3824369 (5'UTR) and rs35629534 (3 'UTR) are located within the adipophilin 
coding region on chromosome 9. The frequencies for alleles A and G of the SNP 
rs3824369 were 0.95 and 0.05, and the frequencies for alleles A and G for the SNP 
rs35629534 were 0.51 and 0.49 (Table 3.10B). All SNPs investigated were in Hardy-
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l 
num was 
also estimated for the SNPs investigated and is presented in Table 3.11. 
Power calculations were carried out for a quantitative trait genetic association 
study [159]. The causal locus was reflected indirectly by rs4932241 and type 1 error was 
fixed to 10-6• Figure 3.4 shows the power profiles as a function of varying coefficients of 
determination for a range of heritability estimates (h2 = 0.05-0.15). As demonstrated by 
this figure, there was sufficient power (/J :::=:0.80) at R2 > 0.4, given our sample size, to 
detect a positive association. 
Table 3.10. Summary of single nucleotide polymorphisms, allele frequencies, and Hardy-
Weinberg equilibriuma SNPs from PLIN(A) and ADFP(B). 
A 
RSNumber Variant Location Frequency HWE (p-value) 
rs4932241 6 NC 3'UTR 0.69 I 0.31 0.468 
rs894160b NG Intron 6 0.74 I 0.26 0.508 
rs2289487b CIA Intron 2 0.68 I 0.32 0.896 
"Hardy-Weingberg was estimated using using :K- analysis. 
bSNPs from the PLIN gene. 
B 
RS Number Variant Location Frequency HWE (p-value) 
rs3824369c NG 5'UTR 0.95 I 0.05 0.531 
rs35629534c NG 3'UTR 0.51 I 0.49 0.910 
"Hardy-Weingberg was estimated using using :K- analysis. 
cSNPs from the ADFP gene. 
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N/D' rs4932241 rs894160 rs2289487 rs3824369 rs35629534 
rs4932241 < 10-16 < 10-t6 0.151 0.777 
rs894160 1230 < 1 o-16 0.189 0.801 
rs2289487 1255 1231 0.556 0.413 
rs3824369 1256 1232 1257 < 10-16 
rs35629534 1245 1220 1245 1246 
The genotype effect of the three SNPs analyzed from the P LIN locus and the two 
SNPs analyzed from the ADFP locus on markers of obesity and semm lipids are found in 
Table 3.12. We tested for associations between the five SNPs and %BF, cholesterol, 
HDL-c, LDL-c, and TAG using multiple regression analyses with gender and age as 
model covariates. No significant association was found between the three perilipin SNPs 
tested and %BF or with serum lipids. No significant association was found between the 
two ADFP SNPs analyzed and HDL-c or TAG. In addition, no significance was found 
between ADFP SNP rs35629534 and cholesterol, LDL-c or %BF. A significant 
association was found between ADFP SNP rs3824369 and cholesterol, LDL-c and %BF. 
Carriers ofthe major allele ofrs3824369 had significantly higher fasting levels ofLDL-c 
(Table 3.13). Carriers of the major allele of rs3824369 had significantly higher fasting 
levels of cholesterol compared to homozygote carriers of the minor allele (Table 3.14). 
In addition, carriers of the major allele of SNP rs3824369 had significantly higher %BF 
compared to homozygote carriers of the minor allele (Table 3.15). To our knowledge this 
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is the fir£t repQ&i of a.a asseeiatien between a S~~P in ADff and vartattons m body fat or 
serum lipids in an adult population. 
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Figure 3.4. Power profiles as a function of varying coefficients of determination for a range 
of heritability estimates. 
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Multiple regression using ari allele dosage or additive model were used for quantitative trait analyses to 
assess the association between P LIN variants and markers of obesity and serum lipids. Sex and age were 
included as model covariates. 
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; PUN, Perilipin; 
•p values based on 10,000 permutations. 
bSNPs from the PLIN gene. 
0 SNPs from the ADFP gene. 
Table 3.13: Serwn LDL-c levels according to ADFP genotype. 
Genotype n LDL-c (mmol/1) 
rs3824369 
AA 
AG 
GG 
1146 
116 
4 
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3.12 ± 0.87 
3.29 ± 1.07 
2.64 ± 1.15 
Table ll4: ~erum ekelestemlle•ol~ accmding tu Af)"Ji? genotype. 
Genotype n 
rs3824369 
AA 
AG 
GG 
1146 
116 
4 
Cholesterol 
(mmoVI) 
5.20 ± l.O 1 
5.35 ± 1.22 
4.54 ± 1.46 
Table 3.15: DXA measured percentage body fat according to ADFP genotype. 
Genotype n %BF 
rs3824369 
AA 
AG 
GG 
1146 
116 
4 
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34.8 ± 8.6 
35.0 ± 8.6 
33.2 ± 9.5 
4a: Comparison of the classification of obesity by BMI versus dual-energy x-ray 
absorptiometry. 
Our study, involving a large sample from the Newfoundland population, 
demonstrates the limited ability of BMI to accurately estimate adiposity. We have 
revealed a large discrepancy between BMI- and DXA-defined adiposity status that is both 
gender and age specific. Almost one half of women and one third of men were 
misclassified by BMI criteria compared to %BF criteria determined by DXA. A 
significant proportion of obese individuals were classified as either normal weight or 
overweight according to BMI criteria. This poses serious health consequences on a 
population level as the opportunity to intervene and reduce health risk in these 
individuals is lost. Overall, BMI had the poorest ability to predict true adiposity in 
normal weight and obese women, and in overweight and obese men. Furthermore, this 
misclassification was influenced by age, with younger women (under 40 years old) 
demonstrating the largest discrepancy between the two methods. We also found 
significant inter-subject variability in %BF for any given BMI value. 
The idea that BMI is imprecise is not a new concept. It has previously been 
shown that BMI is not accurate at predicting adiposity status in the normal to mildly 
obese range [11, 160-161] as well as in severely obese individuals [162]. In particular, 
BMI was found not to be accurate at predicting obesity in individuals with a body mass 
less than 80 kg compared to %BF determined by DXA [160]. Similarly a significant 
number of people with a BMI below 30 were actually obese when classified by %BF 
determined by Bioelectric Impedance Analysis (BIA) [11]. A more recent study, 
involving a large multiethnic sample from the US population found BMI to have limited 
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obesity having good specificity when compared to BIA-defined obesity BMI had low 
sensitivity, missing nearly half of %SF-determined obese people. These findings suggest 
that BMI may not be accurate at assessing adiposity status in normal w ight and 
overweight individuals. Our study included all ranges of BMI and %BF (16.0 - 54.3 
kg.m-2 and 4.6- 59.9 %, respectively) and revealed a slightly higher discrepancy. 
We observed gender differences in the discrepancy between the two methods. 
Although there was good agreement between BMI and DXA for overweight women, 
BMI had limited ability to predict the correct weight classification for normal weight and 
obese women. In men, the greatest discrepancy was evident in the overweight and obese 
groups. Gender differences in BMI accuracy have previously been shown. In men, BMI 
correlates better with lean mass compared to %BF however in women BMI correlates 
better with %BF [161]. This may explain why there was a greater discrepancy between 
BMI and %BF-defmed adiposity status in overweight men but not in women. 
Furthermore, the association between BMI and %BF differs between males and females. 
Males demonstrate a linear relationship between these two parameters while females 
demonstrate a curvilinear relationship [162] which may explain why we observed a high 
discrepancy between BMI- and DXA-defined normal weight women but not men. 
Gender differences in body composition are a profound physiological ph nomenon 
however standard WHO BMI criteria do not accommodate for this. Our results suggest 
that this problem needs addressing. A re-adjustment of obesity criteria to include 
accommodations for gender differences will increase the accuracy of BMI to predict 
adiposity in both males and females. 
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We tt:lse Mutl' !:ed om data after stratifying t'ema1es accordmg to age groups. The 
largest discrepancy between BMI and DXA weight classifications was evident in women 
under the age of 40 while there was moderate to good agreement between the two 
methods in older women. These results are surprising as previous studies have found that 
the diagnostic performance of BMI diminishes as age increases [ 161], likely due to an 
increase in the ratio of fat mass to fat free mass that is evident with age [163]. Further 
studies are warranted to address the potential mechanism surrounding this phenomenon. 
Obesity criteria based on %BF are age specific however, BMI criteria are identical across 
all age groups. From our results it is apparent that BMI cannot accurately reflect age-
related changes in adiposity. 
Our analysis was originally performed usmg %BF criteria from earlier 
publications by Dr. Bray. Bray's original obesity criteria (defined as BF > 25 % in men 
and BF > 33% in women) lacked any adjustment for age or ethnicity [164] . Using these 
criteria, we found that approximately 72% of obese females and 54% of obese males 
were misclassified as normal weight or overweight according to BMI criteria. Our 
current results indicate that the new Bray body fat classifications (Table 1.1) [30] are a 
better fit to BMI criteria, however a significant margin of error still remains between the 
two methods. It is evident that age, gender and ethnicity-specific criteria are necessary 
for more accurate BMI calculations that reflect %BF. 
The findings from our study highlight the importance of using caution when 
defining adiposity status using BMI criteria. Although previous studies have 
demonstrated similar trends, most have small sample sizes [19, 165-166] or have used 
less accurate methods to estimate %BF such as BIA or skin fold thickness [ 11 , 161, 167]. 
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T9o tl::le eest ef e ttr kno~ledge, this is tire thst study of tts R:1hl1 tO demonstrate a 
discrepancy between BMI- and DXA- defined adiposity in a large cohort containing both 
men and women of all different age groups. Nevertheless, our study is not without 
limitations. Other methods to measure adiposity, such as BIA, are cheaper and easier to 
use, despite their reported limitations. Our study was also limited in the number of male 
participants and ethnic groups. Future studies investigating the discrepancy between 
BMI- and DXA-defined adiposity are warranted in a larger male cohort and in other 
populations. 
In summary, we compared BMI weight classifications to DXA-determined weight 
classifications based on %BF in 1691 adult Newfoundlanders. BMI misclassified 42% of 
women and 32.5% of men into an incorrect obesity category. The rnisclassification was 
gender specific. The largest discrepancy was seen in normal weight and obese women, 
and in overweight men. BMI misclassifications were also influenced by age, with the 
largest discrepancy observed in women under 40 years old. These findings support 
previous research suggesting revisions of current BMI criteria to include such 
confounding factors as age, gender and ethnicity [ 162, 168-1 69] . Further research is 
needed to help alleviate these problems so that BMI can continue to be used in everyday 
health appraisals. Using the current BMI criteria might be inappropriate as it may 
misdiagnose obese individuals as normal weight. For these reasons, we recommend that 
caution should be taken when BMI is used in clinical and scientific research. 
Page 75 of 106 
The regulation of serum calcium and the metabolism of lipids involve many hormonal 
and physiological factors. Factors such as age, gender, physical activity level, and body 
composition are contributors to variations of serum lipids seen in the general population 
[ 170-171 ]. Consequently, when attempting to reveal true associations between total 
serum calcium and any variable of serum lipids, it is critical to exclude or control as 
many confounding factors as possible for example, age is usually a constant non-
modifiable risk factor for dyslipidemia [172-173]. Total serum cholesterol, LDL-c and 
TAG levels increase with age, while HDL-c levels decrease with age [172]. In the 
present study, age was controlled in all analytical processes. 
Gender is a constant factor that affects most physiological and pathophysiological 
conditions [174]. For example, the liver is an important organ for lipid metabolism and 
significant sex differences in hepatic gene expression have been seen in mice [175]. 
These differences contribute to sex differences in physiology, homeostasis, and steroid 
and foreign compound metabolism. Sex-related differences in gene expression are 
common across organisms including humans [176-177]. Although most findings in our 
present study show similar results between men and women, sex difference in the 
relationship between serum calcium and TAG are evident. The positive associations were 
strong in women in every aspect of the analyses. However, the relatively weak 
associations in men might be due in part to the small sample size compared with women. 
During menopause there are physiological changes that occur and the metabolism in 
pre- and post menopausal women can be very different. This difference can be partly due 
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to the signi fir aut chanse ill timal• ReRBaHe levels m1d the itictease of body fttt assoetatet! 
with menopause. It is usually seen that menopause is associated with potentially adverse 
changes in lipids and lipoproteins [178]. In our study we found that the positive 
associations between serum Ca ++ and abnormalities of lipids were stronger in pre- than in 
post- menopausal women. 
The association between some lipids and serum calcium in humans was reported in a 
number of cross-sectional and longitudinal studies [141 , 150]. These results were 
documented as part of a wide range of epidemiological studies targeting general risk 
factors. De Bacquer and colleagues was the first group to specifically design a study to 
investigate the link of serum calcium with total cholesterol and HDL-c [179]. Although 
age, sex and BMI were considered in the analyses, other potent confounding factors, with 
potentially important roles in influencing either senun calcium or lipid profiles including 
medication use, smoking, magnesium, percent body fat and menopausal status in women, 
were not studied. 
There is a close association between dyslipidernia and obesity, especially central 
obesity [180]. Central obesity is a major factor for dyslipidemia [174, 18 1-1 82]. Proper 
control and exclusion of the factors which influence obesity status would be critical to 
identifying the association between the two variables that we are interested in. A very 
recent study showed that DXA derived abdominal-fat mass was the best predictor of 
blood lipid profiles [183]. The central fat percentage measured by DXA was controlled 
in all analyses in our study. Control of this variable strengthened our findings, leading to 
the conclusion that the associations of calcium status with lipids are independent of the 
influences of age, gender, menopausal status and body fat. 
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8eaentM' life 3tyle in westem comtnies is a t1stt f'attor fbr d)fshpldemta [ 182, 1 84]. 
Decreased physical activity is significantly associated with increased serum cholesterol, 
LDL-c and TAGs and also with decreased serum levels of HDL-c. Physical activity is 
therefore a potent factor affecting circulating levels of lipids. The physical activity levels 
of our subjects were taken into consideration in our data analy es. Importantly, the 
significant associations between serum calcium and lipids largely hold even after the 
control of physical activity levels. 
The use of various medications including multi-vitamin supplements was found in 
nearly 50% of the study participants. This is typical of adult subjects, including the 
young, middle aged, and elderly, recruited from the general population. Due to the 
diversity and different mixes of medications used it is difficult to classify subjects based 
on the type of pharmaceutical effect. Medication can affect serum lipids through many 
mechanisms. For example, endogenous synthesis of cholesterol in the liver is controlled 
through modification of microsomal enzyme 3-hydroxy-3-methylglutaryl- CoA (HMG-
CoA) reductase activity, the rate limiting step. Medications targeting HMG-CoA 
reductase such as statins can effectively lower cholesterol levels and are widely used in 
patients with dyslipidemia [185]. Other medications including fibric acids and nicotinic 
acid also have powerful lipid lowering effects and are widely used in patients with 
metabolic syndrome and DM2 [186]. Other drugs that are not primarily targeting lipids 
may still have lipid altering affects. Moreover oral contraceptives are commonly used in 
women of reproductive age. Oral contraceptives can cause hypertriglyceridemia in some 
women [187]. It is essential to exclude both the primary and the secondary influence of 
all types of medication on the variation of serum lipids. Analyses according to medication 
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~s weEe tftet>efere perfonned. Eqntrlly significant associations were oMervM m non-
medication users although the number of subjects was reduced by about half compared to 
the total group. This may indicate that the positive association between serum calcium 
and lipid profile becomes clearer when not confounded by the influence of medications. 
Serum calcium levels are regulated by the action of PTH. PTH acts to increase the 
concentration of calcium in the blood [188]. PTH regulates serum calcium levels through 
its effects on bone, kidney and intestines. Moreover, PTH increases the activity of !-a-
hydroxylase enzyme, which converts 25-hydroxycholecalciferol to 1,25-
dihydroxycholecalciferol, the active form of vitamin D. Vitamin D regulates serum 
calcium levels by promoting calcium absorption from food in the intestines. Blood 
calcium status is also augmented by re-absorption of calcium in the kidneys as well. PTH 
and vitamin D are the two hormones primarily involved in the regulation of serum 
calcium. The potential influence of these two hormones on the associations between 
serum calcium and lipids were excluded in this study. Moreover the interactions between 
serum calcium, magnesium and phosphorus may potentially modify the concentration of 
these cations. Hence the influence of magnesium and phosphorus was controlled in 
analyses in this study. Positive correlations were simultaneously observed between Ca++ 
and LDL-c, TAG and HDL-c. It seems confusing if we hypothesize that raised levels of 
serum Ca++ is the molecular basis of high LDL-c and TAG. This was an observational 
study and the nature of the :;tudy does not allow us to properly address this ' contradictory 
result'. This seemingly contradictive positive correlation with Ca++ could potentially be 
caused by numerous reasons. One of the explanations might be that the human body tries 
to offset the rising LDL-c and TAG by increasing the good cholesterol, HDL-c, 
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sjmultaneously ObvioYily this i&&Q& 'li'f'8l't'M:t8 further study in the ftttme. To our 
knowledge, this is the first study designed to investigate the relationship between the 
variations of lipids and serum calcium in a large population with a comprehensive control 
of major confounding factors. Owing to the nature of association studies, positive 
associations like that described in this study, cannot establish a cause-effect relationship. 
However, the carefully controlled study design and the strong association revealed in the 
analyses provide strong support for the need for later studies to examine if there is a 
molecular basis for the association between abnormalities of serum lipids and calcium 
variation. 
In summary, this study analyzed the relationship between the abnormalities of serum 
lipids and serum calcium. A positive association was found between serum Ca ++ -C and 
total cholesterol, TAG, HDL-c and LDL-c in women from the general Newfoundland 
population. A similar trend was found in men. Demonstrating a relationship between 
calcium and serum lipids in spite of comprehensive control of major confounding factors 
makes this study unique and further strengthens the possibility of a direct relationship. 
4c: Genetic association study- roles of Perilipin and Adipophilin on obesity 
phenotypes. 
Lipid storage droplets are the energy storehouses of most cellular organisms from 
fungi to mammals [ 189]. These sequestered lipids are used for energy, membrane 
components and other cellular structures. Initial research into these organelles exposed a 
number of proteins that appeared to regulate the building and breakdown of the lipid 
storage droplet [83, 86, 190-191]. Further research revealed a highly conserved family of 
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P'9~iJW aames t:ke PAT t'rotein!5, that ail appeated to assoc1ate wnn hptd storage droplets 
in one way or another [75, 102]. 
Soon after the initial discovery of PAT proteins, a protein named perilipin was 
identified as a potential gatekeeper to the lipid stored in the adipocyte [88, 90, 93]. 
Depending on the metabolic needs of the organism, Perilipin can activate or inhibit the 
breakdown of lipid stores from lipid storage droplets. 
The main role of ADFP appears to be recruitment of triacylglycerides during the 
initial formation of lipid droplets. This is interesting as variations in the functioning of 
ADFP could result in altered levels of stored lipids and of free fatty acids in the blood 
stream. In fact, research has shown that ADFP knockout mice have a reduction in liver 
TAG content with no affect on levels of other lipids within the liver. Chang et a/. 
showed that ADFP knockout mice fed regular chow showed a 60% reduction in hepatic 
TAG [192]. With secretion of TAG in the form oflipoproteins (ex. VLDL) unaffected in 
ADFP knockout mice, it appears that the problem is a storage issue and not a production 
issue. 
With the obvious role of Perilipin and ADFP in the regulation of lipid stores in 
the body, it was hypothesized that variations in these genes would produce noticeable 
phenotype differences in adipose storage at the population level. It was also 
hypothesized that since ADFP is involved in foam cell formation and the regulation of 
triglycerides within these macrophages, that SNPs in the ADFP genome would produce a 
noticeable effect on serum lipid levels at the population level. The analysis consisted of 
investigating whether a genotype effect existed; whether a certain genotype was 
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asseeiftted "itb ~ ignifiemrtly difTetelli body Composftton (%BF) or serum ltptd parameter 
and the results can be found in table 3.12. 
The results for the perilipin analysis show that there was no significant 
associations found between the SNPs analyzed and body composition or for any serum 
lipid parameter (after accounting for gender, age) (Table 3.12). One of the most 
consistent and striking observations regarding perilipin gene polymorphisms is the effect 
of gender on associated metabolic phenotypes with most associations being found mostly 
in women. Our analysis corrected for any effect of gender on the reported results. As 
well, variations in body fat and serum lipids are highly correlated with age. As such we 
accounted for variations due to age in our analysis. 
Perilipin has been associated with human disease in numerous studies (Table 4.1) 
[95-98, 100, 193-195]. The majority of these studies have to do with the association of 
perilipins with obesity and obesity associated diseases. One of the first differences in 
these studies and the work presented in this thesis is that these other studies used BMI to 
measure body fat whereas our study used DXA. As has already been discussed in this 
thesis and published by our lab, BMI misclassifies adiposity status in approximately one-
third of women and men compared with DXA [ 151]. Obviously this would have some 
effect on the results of a genetic association study if one third of subjects were not 
classified correctly into obesity groups. Thus it is hard to compare the results of studies 
that use BMI with studies that use DXA to measure adiposity. In addition, most ofthese 
studies were on small population sizes. Furthermore, since candidate g ne association 
studies have been questioned because of non-replication of results, in part due to small 
Page 82 of 106 
~ample size and over-intetptetatton of <1ata, our stUdy demonstrated a comprehensive 
study design whereby these factors were minimized. 
The other variable investigated was the effect of P LIN variations on serum lipid 
concentrations. There are very few published reports on associations between perilipin 
and other factors of obesity such as serum lipid levels. This may be in part due to the fact 
that perilipin may not be involved in the metabolism or regulation of serum lipids as 
evidence points to its main function as the LSD gatekeeper in adipocytes. However, 
there is some evidence that suggests associations of variations in the P LIN gene with 
serum lipid levels. A study by Jang et al. suggested an association between variations at 
Table 4.1: Single nucleotide polymorphisms in PLIN and metabolic phenotypes in humans 
Polymorphism Allele Population Phenotype Reference 
1243 err c Japanese Males Decreased bone density [10 I] 
(rs2304796) 
6209 TIC c White and Spanish Females Decreased obesity risk [96] 
(rs2289487) 
White Females Increased risk ofDM2 [193] 
10171 A/T T White Females Increased risk ofDM2 I [ 193] (rs81 79043 
11482 G/A A White and Spanish Females Decreased obesity risk [96, 193-1 94] 
(rs894 160) 
Whites Resistance to weight loss [95] 
Koreans with type DM2 Rosiglitizone dependent I [196] 
weight gain 
Asian and White Females Increased risk ofDM2 [100] 
13041A/G A White Females Increased obesity risk i [98] (rs2304795) 
14995 AfT T White Females Increased obesity risk : [98] I 
(rs 1 052700) 
Asian Females Increased obesity risk I [97] 
Asian Females Increased risk of DM2 [ I 00] 
Adapted from Bickel, 2009.[71] DM2= Diabetes Mellitus Type 2 
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the perjljpjn I QC!J~ .wd CblUl8i 8 i,n 88Rtfft ffee ftttty tteids rutd body ftu after cornpfetton of 
a prescribed weight loss program [94]. They fotmd that GG bomozygotes of the Sr P 
1 0076C _ G experienced a significantly higher reduction of serum FF A compared with CC 
homozygotes after adjustment for age, gender and BMI. In addition, G carriers at SNP 
11482G A or A carriers at SNP 14995A T also bad reductions in FFA concentrations 
- -
after a prescribed weight loss program. These results are not unexpected as one would 
predict a reduction in FF A levels secondary to increased activity and a de~.;rease in oral 
intake as was prescribed in the weight loss program in this study. However, one 
interesting finding was that subjects homozygous for the A allele at S1 P 111482 or SNP 
14995 showed an increase in serum FF A after completion of the prescribed weight loss 
program. These results suggest that perilipin may do more than modify the fat content of 
adipocytes and may play a significant role in the determination of serum lipid 
concentrations. 
Our study did not find any association between variations in the perilipin gene 
and serum lipids. Although this may seem in contrast to the results of Jang et al., their 
study differed from our study in a few ways. First, the analysis was carried out using a 
much smaller population (177) than our study (1200). Second, the subjects were of 
different ethnicity (Korean) than the subjects used in our study (white). Third, Jang 
studied different SNPs in the perilipin locus than us. Fourth, they used BMI to measure 
subjects where we used DXA, however this would not be thought to impact on their 
results involving serum lipids. Finally, Jang's group also performed their study on 
subjects who had just finished a prescribed weight loss program. Our subjects were not 
under any such guidelines or manipulations. 
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Another compmable study to out research is work pubhsfied by Qt et a/. (98}. 
This study is more comparable as it used DXA to measure body fat, had a fa irly large 
sample size (734) and used a mostly white population. The main difference between our 
study and that of Qi et al. is that they used different SNPs than us. The NPs Qi et a!. 
used have been well established as being associated with body composiTion in the 
literature. Our focus was to do novel research on the P LIN gene, and tnus we chose 
SNPs not previously reported in obesity research. Qi' s main finding was tha( two S Ps 
(13041A_G, and 14995A_T) were significantly associated with %BF in women. Qi also 
found that women who were homozygous for the minor allele A in the P LIN SNP 11482, 
another well reported PLIN SNP, appeared to have higher LDL-C mea urements. This is 
in agreement to what Jang' s group found for this SNP. In addition, this research agrees 
with earlier research by Mottagui-Tabar et al. in which the A homozygoTe in this SNP 
(PLIN 11482) was associated with increased adipose lipolysis rates and decreased 
adipocyte perilipin concentrations in white women [ 194]. Both basal and stimulated 
lipolysis rates were increased two to four fold and perilipin protein levels were reduced 
by up to 80%. It was hypothesized by Qi et a!. that the elevated fatty acid in circulation 
secondary to the increased levels of lipolysis would increase the rate of FFA influx into 
the liver resulting in altered lipid metabolism and dyslipidemia. This work however, has 
not been duplicated. Our results did not support either of these findings as the SNPs we 
investigated in PLIN in the Newfoundland population did not show any signiticant 
associations with either body fat or serum lipids. 
In summary, since no significant difference xisted between peril ipin genotype 
variations for any SNP investigated and body composition (after accounting to gender 
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the results suggest no relationship exists. Thus, the results of the present study do not 
support a significant role for genetic variations within the peri lipin gene in the regulation 
of body composition and serum lipid profiles in the NL population. 
The results for ADFP analysis showed that SNP rs35629534 did not have any 
significant associations with any of the body fat or serum lipid parameters analyzed. 
SNP rs3824369 did not show any significant associations with serum HDL-C or serum 
TAG levels (Table 3.12). Our results did show a significant association between SNP 
rs3824369 and %BF, serum cholesterol and serum LDL-c after controlling for the effects 
of gender and age (Table 3.12). Carriers of the major allele of rs3824369 had 
significantly higher fasting levels of LDL-c and significantly higher fasting levels of 
serum cholesterol compared to homozygote carriers of the minor allele (Table 3.13, 
Table 3.14). In addition, carriers of the major allele of SNP rs3824369 had significantly 
higher %BF compared to homozygote carriers of the minor allele (Table 3.15). To our 
knowledge this is the first report of an association between a SNP in ADFP and 
variations in body fat or serum lipids. 
Although these results have never been reported before in vivo, there is evidence 
which may explain this association. First is the fact that ADFP is expressed in all cell 
types [107]. This helps understand that the actions of LSD proteins other than perilipin 
are not limited to the storage of fat in adipocytes within fat tissue. The role of ADFP in 
the uptake and release ofT AG and cholesterol in LSDs found in other cell cypes may be 
crucial to the understanding of dyslipidemia. ADFP upregulation in response to lipid 
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loading in hmnan monocytes may a1so offer an explanahon to mcreased serum lipid 
levels found in our study [ 117]. 
Cell based studies produced the first evidence in support of a link between ADRP 
and lipoprotein synthesis. Magnusson's work showed that ADRP overexpression in 
primary rat hepatocytes resulted in increased storage of TAG into LSDs and decreased 
secretion of VLDL [1 97]. They also showed that ADRP knockout hepatocytes had 
decreased storage of TAG increased VLDL secretion and increased beta oxidation, 
supposedly to handle the excess FF A. 
As ADFP is involved with lipid metabolism and expressed ubiquitously in the 
body it makes sense that a significant association was fotmd in our population. However, 
caution should be taken as the sample size that contained the minor allele for SNP 
rs3824369 was quite small and thus the results may be erroneous for just this fact. 
However, these results will serve as strong preliminary findings for further investigation 
in other studies. 
Page 87 of 106 
Obesity continues to be one of the most important global health threats for both 
adults and children. Over one third of the world's population is overweight or obese with 
these estimates continuing to grow every year. Kelly et al. estimates that this number 
will increase upwards of 60% by the year 2030 [2]. In Canada, this problem is as severe 
if not worse with over 36% either overweight or obese [5]. The province of 
Newfoundland and Labrador has one of the highest rates of obesity in Canada, especially 
in women [6-7]. 
For many years the definition of obesity has been largely based on measurements 
of BMI. Our study showed that BMI rnisclassified 42% of women and 32.5% of men 
into an incorrect obesity category. The misclassification was gender specific and 
influenced by age, with the largest discrepancy observed in women under 40 years old. 
BMI is a very useful tool as it is inexpensive, non-invasive and easy to perform. 
We do not recommend for individuals to stop using BMI in everyday use as it is very 
useful tool to follow ones weight loss or to give a broad overview on ones potential 
obesity status. However, when BMI is used for research or clinical reasons, care should 
be taken as there may be large inaccuracies in the results and a more specific measure of 
body fat should be used. 
Calcium has long been thought to be involved in the etiology of some forms of 
dyslipidernia. However this relationship has never fully been inv stigated while 
controlling for confounding factors such as age gender, medication use, disease status, 
menopause, parathyroid hormone and 23-0H-vitamin D status. Our study performed 
such an experiment and determined that abnormalities in serum lipid protiles were 
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significmrtly conetated with a1tetect serum ca** levels Independent of the aforemenhon a 
confounding factors further strengthening the possibility of a direct relationship between 
the two. 
The candidate gene association srudy followed up on a well accepted theory that 
adiposity is closely related to the genetics of how lipids are stored and released from fat 
stores in the body. Perilipin and its close cousin adipophilin are unique in that they both 
coat lipid storage droplets. Perilipin is restricted to adipose tissue and steroidogenic cells 
and adipophilin is expressed ubiquitously in all cell types. We have demonstrated that 
genetic variants within the perilipin gene do not appear to have a significant association 
with obesity phenotypes in the Newfoundland and Labrador population. We also 
demonstrated that genetic variants within the adipophilin gene did appear to have a 
significant association with obesity phenotypes in the Newfoundland and Labrador 
population. Moreover, percentage body fat measure by DXA and serum LDL-c and 
cholesterol were positively associated with a single nucleotide polymorphism 
(rs3824369) in the adipophilin gene. Subjects who were homozygous forth major allele 
of the polymorphism had significantly higher levels of body fat, LDL-c and senun 
cholesterol than subjects who were homozygous for the minor allele. This finding was 
independent of gender and age. Although the number of homozygotes for the minor 
allele was quite small, if this result holds true it will be the first such publication linking a 
SNP in adipophilin with obesity phenotypes such as these. 
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6.1: Comparison of the classification of obesity by BMI versus dual-energy x-ray 
absorptiometry. 
1. Although 1691 subjects is a reasonable number to perform analyses on, 
replication of our results with another cohort would be preferable. 
2. Even though recruitment of men was difficult, we did manage to include 3 70 
men in our study. However, a larger cohort of men would be preferred to 
increase the power in our findings. 
3. Due to population constraints, our subjects were limited to white Canadians of 
European decent. In order for our results to have a more worldwide 
application, subjects of other races and nationalities would need to be studied 
in large cohorts such as ours. 
6.2: Abnormality of serum lipids are independently associated with increased 
serum calcium levels in the adult Newfoundland population. 
1. Although 1269 subjects is a reasonable number to perform analyses on, 
replication of our results with another cohort would be preferable. 
2. Even though recruitment of men was difficult, we did manage to include 267 
men in our study. However, a larger cohort of men would be preferred to 
increase the power in our findings. 
3. Due to population constraints, our subjects were limited to white Canadians of 
European decent. In order for our results to have a more worldwide 
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appl.i~a~9B1 sMBjeets &f ot:het taces and naliona1tt1es woUld need to be tudted 
in large cohorts such as ours. 
6.3: Genetic association study - roles of Perilipin and Adipophilin on obesity 
phenotypes. 
l. Although 1691 subjects is a reasonable number to perform association 
analyses, replication of our results with another cohort would be preferable. 
2. Even though recruitment of men was difficult, we did manage to include 370 
men in our study. However, a larger cohort of men would be preferred to 
increase the power in our findings. 
3. Due to population constraints, our subjects were limited to white Canadians of 
European decent. In order for our results to have a more worldwide 
application, subjects of other races and nationalities would need to be studied 
in large cohorts such as ours. 
4. Although the location of the SNPs chosen was well thought out as to be 
possible important locations within the locus of each of perilipin and 
adipophilin, the low number of SNPs genotyped decreases the power of this 
study. Increasing the number of S1 Ps studied within each gene to 6 or more 
would bring this research up to current standards for association smdied on 
candidate genes. Not only would this increase the validity of our study but 
would also help to strengthen any findings that we make. Unfortunately, time 
and funding were not available for us to continue the research in this direction. 
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7.1: Comparison of the classification of obesity by BMI versus dual-energy x-ray 
absorptiometry. 
1. This research was originally planned to be used to create new criteria for BMI 
to help decrease the discrepancy found between BMI and more accurate 
anthropometric tools. It is hoped that one day it will be used for this purpose. 
7.2: Abnormality of serum lipids are independently associated with increased 
serum calcium levels in the adult Newfoundland population. 
1. It is planned that these results will be correlated with dietary intake for further 
understanding into serum calcium effects on serum lipids. 
7.3: Genetic association study - roles of Perilipin and Adipophilin on obesity 
phenotypes. 
1. Since the completion of this original research, more than 700 subjects have 
been recruited into the CODING study. The remaining subjects will be 
genotyped. 
2. In addition to genotyping the new recruited subjects, more SNPs will need to 
be genotyped within each gene to increase the power of the findings . These 
new SNPs will be strategically chosen based on their location, linkage 
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EliseEJ:Nilierittnt ~ith the 8NPs already genotypea and new SNPs not yet 
genotyped and as well based on published results in the literahire. 
3. Information on dietary intake of fat has been collected from study participants 
and analyzed using the Willet Food Frequent Questionnaires and the 
Nutribase clinical nutritional software. Combining this information with 
fasting lipid profiles already collected from study subjects and the results from 
the SNPs genotyping analysis will help provide understanding of the 
interactions between genetic variations in LSD associated genes and dietary 
fat consumption on serum cholesterol LDL-c, HDL-c and TAGs. Preliminary 
data has been produced and results are encouraging. 
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